| 19569819 |
TRISPECIFIC COMPOSITIONS COMPRISING IL-2, VEGF BINDING DOMAINS, AND PD-1 BINDING DOMAINS |
Bright Peak Therapeutics AG |
GODDARD, LAURA B |
1642 |
§103§112DP |
Non-Final OA |
— |
Pending |
Mar 17, 2026 |
| 19548526 |
HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
University of Basel |
PERREIRA, MELISSA JEAN |
1618 |
§102§103DP |
Non-Final OA |
— |
Pending |
Feb 24, 2026 |
| 19545401 |
FORMULATIONS OF VIMSELTINIB |
Deciphera Pharmaceuticals, LLC |
PAK, JOHN D |
1699 |
§103§112DP |
Final Rejection |
— |
Pending |
Feb 20, 2026 |
| 19544595 |
FORMULATIONS OF VIMSELTINIB |
Deciphera Pharmaceuticals, LLC |
LEE, SIN J |
1613 |
§102§103§112 |
Final Rejection |
— |
Pending |
Feb 19, 2026 |
| 19434846 |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RADIATION INDUCED TOXICITY |
Zydus Lifesciences Limited |
OH, TAYLOR V |
1625 |
§103 |
Final Rejection |
— |
Pending |
Dec 29, 2025 |
| 19433697 |
METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION |
Character Biosciences, Inc. |
HELLMAN, KRISTINA M |
1654 |
§112 |
Final Rejection |
— |
Pending |
Dec 26, 2025 |
| 19432924 |
AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN |
Kashiv Biosciences, LLC |
REGLAS, GEORGIANA C |
1651 |
§102 |
Final Rejection |
— |
Pending |
Dec 24, 2025 |
| 19432904 |
AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN |
Kashiv Biosciences, LLC |
MCDERMOTT, JEANNIE |
1776 |
§103§112Other |
Non-Final OA |
— |
Pending |
Dec 24, 2025 |
| 19397828 |
TREATMENT OF DIABETIC RETINOPATHY USING ENDOTHELIN RECEPTOR ANTAGONISTS |
Perfuse Therapeutics, Inc. |
BASQUILL, SEAN M |
1614 |
§103 |
Final Rejection |
— |
Pending |
Nov 21, 2025 |
| 19353469 |
COMPOSITIONS, DEVICES, AND METHODS RELATING TO USE OF AN AMNIOTIC MEMBRANE FETAL TISSUE PRODUCT |
BIOTISSUE HOLDINGS INC. |
WESTON, ALYSSA G |
1633 |
§102§103 |
Final Rejection |
— |
Pending |
Oct 08, 2025 |
| 19348728 |
ORAL MUCOSAL FORMULATIONS OF ASPIRIN |
Aspire Biopharma Holdings, Inc. |
SONG, JIANFENG |
1613 |
§103DP |
Final Rejection |
— |
Pending |
Oct 02, 2025 |
| 19344208 |
CRYOGENIC COOLING SYSTEM WITH A RESONANT EXPANDER |
R7 Instruments, Inc. |
LARGI, MATTHEW THOMAS |
3746 |
§102§112 |
Final Rejection |
— |
Pending |
Sep 29, 2025 |
| 19338730 |
TRANSDERMAL DEXMEDETOMIDINE FOR TREATING AGITATION |
Teikoku Pharma Usa, Inc. |
HAVLIN, ROBERT H |
1626 |
§103DP |
Final Rejection |
— |
Pending |
Sep 24, 2025 |
| 19339016 |
TIERED TESTING FOR HIGH RISK POPULATIONS |
Harbinger Health, Inc. |
SMITH, EMILIE ALINE |
1686 |
§101§112DP |
Non-Final OA |
— |
Pending |
Sep 24, 2025 |
| 19288411 |
MULTI-TIERED TESTING FOR TRACKING DISEASE HETEROGENEITY |
Flagship Pioneering Innovations Vi, LLC |
SKIBINSKY, ANNA |
1635 |
§101§103 |
Non-Final OA |
50d overdue |
Pending |
Aug 01, 2025 |
| 19284259 |
SYSTEMS AND METHODS FOR DENTAL TREATMENT WITH EKF |
T33 Dental, Inc. |
GONZALEZ, LEI NMN |
3783 |
§103 |
Final Rejection |
14d |
Pending |
Jul 29, 2025 |
| 19282184 |
PROCESS OF PURIFICATION OF PROTEIN |
Kashiv Biosciences, LLC |
ROONEY, NORA MAUREEN |
1641 |
§112DP |
Non-Final OA |
— |
Pending |
Jul 28, 2025 |
| 19244554 |
METHODS TO MODIFY BEHAVIORS TO MITIGATE IMPACT OF PREDICTION INACCURACIES FOR LATER TIME WINDOWS IN AMD SYSTEMS |
Insulet Corporation |
GILLIGAN, CHRISTOPHER L |
3683 |
§103 |
Final Rejection |
— |
Pending |
Jun 20, 2025 |
| 19220387 |
SYSTEMS AND METHODS FOR DETERMINING ASSET IMPORTANCE IN SECURITY RISK MANAGEMENT |
Bitsight Technologies, Inc. |
MANIWANG, JOSEPH R |
2453 |
DP |
Non-Final OA |
— |
Pending |
May 28, 2025 |
| 19211805 |
ON-BODY INTERLOCK FOR DRUG DELIVERY DEVICE |
Insulet Corporation |
STIGELL, THEODORE J |
3783 |
§103§112DP |
Non-Final OA |
— |
Pending |
May 19, 2025 |
| 19197571 |
SYSTEMS AND METHODS FOR DATA STRUCTURE ANALYSIS |
Gestalt Tech Corp. |
SAMARA, HUSAM TURKI |
2161 |
§103 |
Final Rejection |
36d overdue |
Pending |
May 02, 2025 |
| 19196457 |
IgE PROTEASES AND USES THEREOF |
Seismic Therapeutic, Inc. |
DESAI, ANAND U |
1655 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 01, 2025 |
| 19187537 |
ELECTROCHEMICAL ACTUATORS AND ACTUATOR ARRAYS |
Insulet Corporation |
LETTMAN, BRYAN MATTHEW |
3746 |
§103 |
Final Rejection |
43d |
Pending |
Apr 23, 2025 |
| 19180988 |
EARLY MEAL DETECTION AND CALORIE INTAKE DETECTION |
Insulet Corporation |
DUNHAM, JASON B |
3686 |
§101§103 |
Non-Final OA |
— |
Pending |
Apr 16, 2025 |
| 19172026 |
IMAGE-BASED DETECTION OF OPHTHALMIC AND SYSTEMIC DISEASES |
Antinous Technology Company Limited |
WINDSOR, COURTNEY J |
|
§102§103Other |
Non-Final OA |
— |
Pending |
Apr 07, 2025 |
| 19171119 |
SYSTEM TO CREATE CELLULAR LYSIS AND DELIVER FLUIDS INTRATUMORALLY |
Syncromune, Inc. |
SHOULDERS, ANNIE LEE |
3794 |
§102§103 |
Non-Final OA |
— |
Pending |
Apr 04, 2025 |
| 19087070 |
POLY-DONOR CD4+ T CELLS EXPRESSING IL-10 AND USES THEREOF |
Tr1X, Inc. |
NGUYEN, QUANG |
1631 |
§103§112Other |
Non-Final OA |
— |
Pending |
Mar 21, 2025 |
| 19084902 |
AUTOMATED PLATFORM FOR GENERATING INTERACTIVE VIDEOS |
Jbf Interlude 2009 Ltd. |
OCAK, ADIL |
2426 |
§103 |
Final Rejection |
— |
Pending |
Mar 20, 2025 |
| 19079820 |
IMAGE-GUIDED ROBOTIC SYSTEM WITH REMOTE GUIDANCE, IMAGE STEERING, MULTI-PLANE IMAGING, NEEDLE VISUALIZATION ENHANCEMENT, AND CONSTRAINED BACKDRIVING |
Mendaera, Inc. |
BRUTUS, JOEL F |
3797 |
§103 |
Final Rejection |
30d overdue |
Pending |
Mar 14, 2025 |
| 19073748 |
SYSTEMS AND METHODS FOR CUSTOMIZING ONLINE GAMING |
Magnetic Games AB |
ADAMS, CARL |
2627 |
§102§103 |
Non-Final OA |
— |
Pending |
Mar 07, 2025 |
| 19068816 |
ION IDENTIFICATION USING ION MOBILITY SPECTROMETRY |
Micromass UK Limited |
LE, THANG XUAN |
2858 |
§102Other |
Non-Final OA |
— |
Pending |
Mar 03, 2025 |
| 19047061 |
METHODS AND SYSTEMS FOR ANALYZING IMAGES FOR PRECISION TISSUE MICROARRAY CONSTRUCTION |
Noetik Inc. |
CROCKETT, JOSHUA BRIGHAM |
2661 |
§103§112 |
Non-Final OA |
— |
Pending |
Feb 06, 2025 |
| 19039593 |
FABRICATION OF POLYCRYSTALLINE SILICON NITRIDE FIBERS |
Bluehalo, LLC |
DAIGLER, CHRISTOPHER PAUL |
1741 |
§101§103 |
Non-Final OA |
— |
Pending |
Jan 28, 2025 |
| 19035537 |
APPARATUS FOR GLYCEMIC CONTROL |
Insulet Corporation |
KOLOSOWSKI-GAGER, KATHERINE |
3687 |
§101§103 |
Final Rejection |
42d overdue |
Pending |
Jan 23, 2025 |
| 19022962 |
METHOD AND SYSTEM FOR ASSET ROUTING |
Lob.Com, Inc. |
WALLACE, JOHN R |
2682 |
§103Other |
Non-Final OA |
— |
Pending |
Jan 15, 2025 |
| 19022649 |
METHOD FOR PREPARING METALLIC COBALT THIN FILM AND METHOD FOR PREPARING COBALT SILICIDE THIN FILM |
BEIJING SUPERSTRING ACADEMY OF MEMORY TECHNOLOGY |
TALBOT, BRIAN K |
1712 |
§103§112 |
Final Rejection |
— |
Pending |
Jan 15, 2025 |
| 19013936 |
SYSTEMS AND METHODS FOR UNDERGROUND STORAGE OF STORM AND OTHER WATER SOURCES |
Underground Industries LLC |
TOLEDO-DURAN, EDWIN J |
3678 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Jan 08, 2025 |
| 19012213 |
SYSTEM AND METHOD FOR TREATMENT OF MEDICAL CONDITIONS USING MULTIPLE BLOOD PRESSURE SENSORS |
Aktiia SA |
YOON, CHANEL J |
3791 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Jan 07, 2025 |
| 19004969 |
LOGGING AND ANALYZING ROBOTIC PICKING DATA |
Oxipital AI Inc. |
NELESKI, ELIZABETH ROSE |
3658 |
§103 |
Final Rejection |
14d |
Pending |
Dec 30, 2024 |
| 18985953 |
METHOD FOR MANUFACTURING A NEW PROSTHESIS |
Ottobock SE & Co. Kgaa |
ERDMAN, CHAD G |
2116 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Dec 18, 2024 |
| 18980378 |
VPS34 INHIBITORS AND METHODS OF USE THEREOF |
Deciphera Pharmaceuticals, LLC |
NESTOR, DONNA MICHELLE |
|
§103§112 |
Non-Final OA |
— |
Pending |
Dec 13, 2024 |
| 18974588 |
NINTEDANIB AND NINTEDANIB COMBINATION DRY POWDER COMPOSITIONS AND USES |
Avalyn Pharma Inc. |
ZHANG SPIERING, DONGXIU |
1616 |
§103§112DP |
Non-Final OA |
— |
Pending |
Dec 09, 2024 |
| 18971800 |
SOLID FORMS OF AN ULK INHIBITOR |
Deciphera Pharmaceuticals, LLC |
SEITZ, ANTHONY JOSEPH |
1629 |
§103§112 |
Non-Final OA |
— |
Pending |
Dec 06, 2024 |
| 18870188 |
SYSTEM AND METHODS FOR PREDICTING GLAUCOMA INCIDENCE AND PROGRESSION USING RETINAL PHOTOGRAPHS |
Antinous Technology Company Limited |
FUJITA, KATRINA R |
2672 |
§102§103 |
Non-Final OA |
— |
Pending |
Nov 27, 2024 |
| 18958722 |
COMPOSITE BUILDING MATERIALS AND METHODS OF MANUFACTURE |
Rise Building Products LLC |
CHOI, PETER Y |
1786 |
§103 |
Final Rejection |
— |
Pending |
Nov 25, 2024 |
| 18953864 |
CRYSTALLINE FORMS OF ALDH2 MODULATORS |
Sophrosyne Pharmaceuticals Limited |
BRAUN, MADELINE E |
|
§101§112Other |
Non-Final OA |
— |
Pending |
Nov 20, 2024 |
| 18945759 |
SYSTEMS AND METHODS FOR PATIENT TARGETED THERAPY DEVELOPMENT |
Flagship Pioneering Innovations Vi, LLC |
PAULS, JOHN A |
3683 |
§101§103DP |
Final Rejection |
23d overdue |
Pending |
Nov 13, 2024 |
| 18941986 |
3-(SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME |
Deuterx, LLC |
WARD, PAUL V |
1622 |
DP |
Non-Final OA |
— |
Pending |
Nov 08, 2024 |
| 18941833 |
COSMETIC COMPOSITIONS |
Eleblend LLC |
PHAN, DOAN THI-THUC |
1613 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Nov 08, 2024 |
| 18938818 |
COMPACT LIQUID CHROMATOGRAPHY SYSTEM PROVIDING THERMAL MANAGEMENT AND DETECTION |
Waters Technologies Corporation |
SINGER, DAVID L |
2855 |
§103Other |
Non-Final OA |
— |
Pending |
Nov 06, 2024 |
| 18936787 |
DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS |
Ensoma, Inc. |
PAGUIO FRISING, MICHELLE F |
1651 |
§103§112DP |
Non-Final OA |
— |
Pending |
Nov 04, 2024 |
| 18862402 |
METHOD FOR SETTING UP AN ORTHOPAEDIC DEVICE |
Ottobock SE & Co. Kgaa |
WAGGLE, JR, LARRY E |
3775 |
§102§112 |
Non-Final OA |
— |
Pending |
Nov 01, 2024 |
| 18932353 |
MANUALLY OPERATED PUMP ASSEMBLY |
Kickstart International, Inc. |
PEKARSKAYA, LILYA |
3746 |
§102§103 |
Final Rejection |
— |
Pending |
Oct 30, 2024 |
| 18860528 |
PROLONGED AIR LEAK PERCEPTION |
Texas Medical Center |
MONTICELLO, WILLIAM THOMAS |
3682 |
§101§102 |
Non-Final OA |
35d |
Pending |
Oct 25, 2024 |
| 18925636 |
WEARABLE SENSOR HAVING AN ADHESIVE, AND A MANUFACTURING METHOD |
Occam Bci, Inc. |
XU, JUSTIN |
3791 |
§103 |
Non-Final OA |
— |
Pending |
Oct 24, 2024 |
| 18859955 |
PRODUCTION OF RNA POLYNUCLEOTIDES ENCODING PICORNAVIRUS |
Elevatebio Technologies, Inc. |
SALVOZA, M FRANCO G |
1653 |
§103§112 |
Non-Final OA |
— |
Pending |
Oct 24, 2024 |
| 18916566 |
PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-HUMAN TSLP RECEPTOR ANTIBODIES AND METHODS OF USING THE SAME |
Upstream Bio, Inc. |
DUFFY, PATRICIA ANN |
1645 |
DP |
Non-Final OA |
— |
Pending |
Oct 15, 2024 |
| 18913635 |
SYSTEM FOR PURIFICATION OF BIOACTIVE PROTEINS, AND RELATED METHODS |
HP Bioengineering, LLC |
NGUYEN, BOI-LIEN THI |
1779 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 11, 2024 |
| 18909461 |
WEARABLE COMPUTER POINTING APPARATUS |
6Degrees Ltd. |
LEIBY, CHRISTOPHER E |
2621 |
§103 |
Non-Final OA |
11d overdue |
Pending |
Oct 08, 2024 |
| 18907930 |
ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS |
Parcus Medical, LLC |
BONAPARTE, AMY C |
1692 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Oct 07, 2024 |
| 18854263 |
TYROSINE KINASE INHIBITORS |
University Court Of The University Of Edinburgh |
CHAO, ALLEN |
1629 |
§103DP |
Non-Final OA |
— |
Pending |
Oct 04, 2024 |
| 18853369 |
METHOD TO MANUFACTURE BIOFUEL |
Sixring Inc. |
ROBINSON, RENEE E |
1772 |
§103§112 |
Non-Final OA |
— |
Pending |
Oct 01, 2024 |
| 18852039 |
TYK2 INHIBITORS AND USES THEREOF |
Alumis Inc. |
ROCHELLE, CIERRA MARIE |
1627 |
§103§112DP |
Non-Final OA |
— |
Pending |
Sep 27, 2024 |
| 18850020 |
MASS SPECTROMETER HAVING HIGH DUTY CYCLE |
Micromass UK Limited |
WANG, JING |
2881 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 23, 2024 |
| 18850007 |
MASS SPECTROMETER HAVING HIGH DUTY CYCLE |
Micromass UK Limited |
KALISZEWSKI, ALINA ROSE |
2881 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 23, 2024 |
| 18887514 |
SPECIALLY FORMULATED COMPOSITIONS OF INHALED NINTEDANIB AND NINTEDANIB SALTS |
Avalyn Pharma Inc. |
RONEY, CELESTE A |
1612 |
§103§112DP |
Non-Final OA |
— |
Pending |
Sep 17, 2024 |
| 18886015 |
SYSTEMS AND METHODS FOR NONLINEAR VIDEO PLAYBACK USING LINEAR REAL-TIME VIDEO PLAYERS |
Jbf Interlude 2009 Ltd. |
DOSHI, AKSHAY |
2422 |
§103Other |
Final Rejection |
— |
Pending |
Sep 16, 2024 |
| 18885280 |
PATHOGEN DIAGNOSTIC TEST |
Octant, Inc. |
SALVOZA, M FRANCO G |
|
§112 |
Non-Final OA |
— |
Pending |
Sep 13, 2024 |
| 18883710 |
ADHESIVE PATCH AND SYSTEM FOR WEARABLE MEDICAL DEVICE |
Insulet Corporation |
VOKES, KATHLEEN PAIGE |
3783 |
§102§103 |
Non-Final OA |
— |
Pending |
Sep 12, 2024 |
| 18829573 |
SAFE DESMOPRESSIN ADMINISTRATION |
Acerus Pharmaceuticals Usa, LLC |
REYNOLDS, FRED H |
1658 |
DP |
Non-Final OA |
— |
Pending |
Sep 10, 2024 |
| 18829953 |
QUINOLINE cGAS ANTAGONIST COMPOUNDS |
The Board Of Regents Of The University Of Texas System |
SEAMAN, D MARGARET M |
1625 |
DP |
Non-Final OA |
— |
Pending |
Sep 10, 2024 |
| 18825624 |
OBSERVATION AND/OR INSPECTION OF A MATERIAL WEB |
Texmag GmbH Vertriebsgesellschaft |
HAIDER, SYED |
2633 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 05, 2024 |
| 18843868 |
SHIELD FOR ION SOURCE ENCLOSURE |
Micromass UK Limited |
OSENBAUGH-STEWART, ELIZA W |
|
§102§103§112 |
Non-Final OA |
— |
Pending |
Sep 04, 2024 |
| 18841749 |
TRIPLE UPTAKE INHIBITOR FOR THE TREATMENT OF ATYPICAL DEPRESSION |
Noema Pharma AG |
ARCORIA, PAUL JOSEPH |
1621 |
§102§103 |
Non-Final OA |
— |
Pending |
Aug 27, 2024 |
| 18841235 |
MEASURING IONS WITH CHARGE REDUCTION |
Micromass UK Limited |
WANG, JING |
2881 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Aug 23, 2024 |
| 18804372 |
SAFETY CONSTRAINTS FOR A CONTROL ALGORITHM BASED DRUG DELIVERY SYSTEM |
Insulet Corporation |
GOLLAMUDI, NEERAJA |
3783 |
§103§112 |
Non-Final OA |
— |
Pending |
Aug 14, 2024 |
| 18799908 |
SYSTEMS AND METHODS FOR DETERMINING EVENT SCHEDULES |
Recentive Analytics, Inc. |
KNIGHT, LETORIA G |
3623 |
§101§103 |
Final Rejection |
— |
Pending |
Aug 09, 2024 |
| 18793315 |
SEPARATING IONS IN AN ION TRAP |
Micromass UK Limited |
MCCORMACK, JASON L |
2881 |
§102§103Other |
Non-Final OA |
— |
Pending |
Aug 02, 2024 |
| 18789272 |
SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH |
Pfizer, Inc. |
VAJDA, KRISTIN ANN |
1624 |
DP |
Non-Final OA |
— |
Pending |
Jul 30, 2024 |
| 18833849 |
NTSR1-TARGETED RADIOPHARMACEUTICALS AND DNA DAMAGE RESPONSE INHIBITOR COMBINATION THERAPY |
Fusion Pharmaceuticals Inc. |
MOSHER, ERIC PARKER |
1612 |
§103§112DP |
Non-Final OA |
— |
Pending |
Jul 26, 2024 |
| 18833468 |
COMPOUNDS AND METHODS OF USE |
Tango Therapeutics, Inc. |
LADD, CAROLYN LOUISE |
1629 |
§112 |
Non-Final OA |
— |
Pending |
Jul 26, 2024 |
| 18833319 |
COMPOUNDS AND METHODS OF USE |
Tango Therapeutics, Inc. |
ROZOF, TIMOTHY R |
1625 |
§112DP |
Non-Final OA |
— |
Pending |
Jul 25, 2024 |
| 18833076 |
CRYSTALLINE FORM OR AMORPHOUS FORM OF MACROCYCLIC COMPOUND OR SALT OR SOLVATE THEREOF |
Ascentage Pharma Group Corp Limited |
LADD, CAROLYN LOUISE |
|
§103 |
Non-Final OA |
— |
Pending |
Jul 25, 2024 |
| 18833315 |
COMPOUNDS AND METHODS OF USE |
Tango Therapeutics, Inc. |
LADD, CAROLYN LOUISE |
1622 |
§112 |
Non-Final OA |
— |
Pending |
Jul 25, 2024 |
| 18783250 |
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS |
Fulcrum Therapeutics, Inc. |
SEAMAN, D MARGARET M |
1625 |
§112 |
Non-Final OA |
— |
Pending |
Jul 24, 2024 |
| 18772865 |
METHOD FOR PREPARING BENZOFURAN DERIVATIVE |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
SANDERSON, LEE E |
3991 |
Other |
Non-Final OA |
— |
Pending |
Jul 15, 2024 |
| 18770318 |
PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF |
Deciphera Pharmaceuticals, LLC |
KIFLE, BRUCK |
1624 |
DP |
Non-Final OA |
— |
Pending |
Jul 11, 2024 |
| 18768886 |
WEARABLE DEVICE FOR TARGETED PERIPHERAL STIMULATION |
Encora, Inc. |
MILLER, CHRISTOPHER E |
3785 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Jul 10, 2024 |
| 18764647 |
METHOD FOR TREATMENT OF PARKINSON'S DISEASE |
Neuroderm, Ltd. |
SHIAO, REI TSANG |
1691 |
§103§112DP |
Non-Final OA |
— |
Pending |
Jul 05, 2024 |
| 18760242 |
METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS |
Candel Therapeutics, Inc. |
WILSON, MICHAEL C |
1638 |
§102§112DP |
Non-Final OA |
— |
Pending |
Jul 01, 2024 |
| 18725665 |
CD4+ T CELLS EXPRESSING IL-10 AND CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF |
Tr1X, Inc. |
HOLTZMAN, KATHERINE ANN |
1646 |
§103§112Other |
Non-Final OA |
— |
Pending |
Jun 28, 2024 |
| 18756649 |
EMBOLIC COMPOSITIONS AND METHODS |
Arsenal Medical, Inc. |
PEPITONE, MICHAEL F |
1767 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Jun 27, 2024 |
| 18753253 |
BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF |
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
FOX, ALLISON M |
1633 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Jun 25, 2024 |
| 18748756 |
METHOD OF TREATMENT OF PARKINSON’S DISEASE |
Neuroderm, Ltd. |
HUI, SAN MING R |
1627 |
§102§103DP |
Non-Final OA |
— |
Pending |
Jun 20, 2024 |
| 18740064 |
HDAC INHIBITORS AND THERAPEUTIC USE THEREOF |
Tango Therapeutics, Inc. |
ANDERSON, REBECCA L |
1626 |
DP |
Non-Final OA |
— |
Pending |
Jun 11, 2024 |
| 18717390 |
SOLID STATE FORMS OF AN FGFR INHIBITOR |
Khora Spv 1. LLC |
FETTEROLF, BRANDON J |
1626 |
§102DP |
Non-Final OA |
— |
Pending |
Jun 06, 2024 |
| 18678378 |
SYSTEMS AND METHODS FOR PREDICTING CYBERSECURITY RISK BASED ON ENTITY FIRMOGRAPHICS |
Bitsight Technologies, Inc. |
NAHAR, SAYEDA S |
2435 |
§103 |
Final Rejection |
— |
Pending |
May 30, 2024 |
| 18675875 |
4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF |
Visen Medical, Inc. |
JONES, DAMERON LEVEST |
1618 |
DP |
Non-Final OA |
— |
Pending |
May 28, 2024 |
| 18675900 |
PREDICTION OF MEAL AND/OR EXERCISE EVENTS BASED ON PERSISTENT RESIDUALS |
Insulet Corporation |
SMALE, AVERY E |
3783 |
§102§103§112 |
Non-Final OA |
— |
Pending |
May 28, 2024 |
| 18673716 |
OXYGEN SENSOR ELEVATOR ASSEMBLY |
Rapid Micro Biosystems, Inc. |
SINGER, DAVID L |
2855 |
§103 |
Final Rejection |
— |
Pending |
May 24, 2024 |
| 18711986 |
HETEROCYCLIC SUBSTITUTED 1,3,4-THIADIAZOLE AND PYRIDAZINE COMPOUNDS AND METHODS OF USING THE SAME |
Rgenta Therapeutics, Inc. |
RAHMANI, NILOOFAR |
1691 |
§112 |
Non-Final OA |
— |
Pending |
May 21, 2024 |
| 18667441 |
1H-BENZO[B]AZEPIN-2(3H)-ONE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER |
Chengdu Anticancer Bioscience, Ltd. |
NESTOR, DONNA MICHELLE |
1627 |
§103§112 |
Non-Final OA |
— |
Pending |
May 17, 2024 |
| 18711470 |
A METHOD OF CONFIGURING A STRING OF PULSES |
Waters Technologies Ireland Limited |
SMYTH, ANDREW P |
2878 |
§101 |
Non-Final OA |
— |
Pending |
May 17, 2024 |
| 18711434 |
TABLET FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE |
Belite Bio, Inc. |
JANOSKO, CHASITY PAIGE |
1613 |
§103§112 |
Non-Final OA |
— |
Pending |
May 17, 2024 |
| 18710312 |
HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME |
Rgenta Therapeutics, Inc. |
MCDOWELL, BRIAN E |
1624 |
§112 |
Non-Final OA |
— |
Pending |
May 15, 2024 |
| 18664718 |
AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF |
Avalyn Pharma Inc. |
TRUONG, QUANGLONG N |
1615 |
DP |
Non-Final OA |
— |
Pending |
May 15, 2024 |
| 18664594 |
SELF-CALIBRATION OF HIGH RESOLUTION MASS SPECTRUM |
Micromass UK Limited |
MASKELL, MICHAEL P |
2878 |
§102§103 |
Non-Final OA |
— |
Pending |
May 15, 2024 |
| 18710558 |
METHODS AND SYSTEMS FOR AUTOMATED SAMPLE PROCESSING |
Erisyon Inc. |
WRIGHT, PATRICIA KATHRYN |
1798 |
§102§103 |
Non-Final OA |
— |
Pending |
May 15, 2024 |
| 18661020 |
METHODS TO DEMONSTRATE PROGRESS TOWARDS FULL ADAPTATION AND TO PRESENT POTENTIAL IMPROVEMENTS THROUGH BEHAVIORAL CHANGES |
Insulet Corporation |
MENDEZ, MANUEL A |
3783 |
§103 |
Non-Final OA |
— |
Pending |
May 10, 2024 |
| 18659379 |
SYSTEM AND METHOD FOR TREATMENT OF PERIODONTIC POCKETS USING DISPOSABLE INSERTS |
Convergent Dental, Inc. |
MORAN, EDWARD JOHN |
3772 |
§103§112Other |
Non-Final OA |
16d |
Pending |
May 09, 2024 |
| 18708545 |
METHODS AND COMPOSITIONS FOR TREATING MICROGLIAL DYSFUNCTION AND IMPROVING METABOLIC DYSFUNCTION |
Albert-Ludwigs-Universität Freiburg |
FAN, LYNN Y |
1759 |
§103 |
Non-Final OA |
— |
Pending |
May 08, 2024 |
| 18658604 |
SELF-AMPLIFYING RNA COMPOSITIONS AND METHODS OF USE THEREOF |
Gritstone Bio, Inc. |
CHESTNUT, BARRY A |
1672 |
§103§112 |
Non-Final OA |
— |
Pending |
May 08, 2024 |
| 18708028 |
METHOD FOR MANUFACTURING GATE-ALL-AROUND TFET DEVICE |
Institute Of Microelectronics, Chinese Academy Of Sciences |
DAS, PINAKI |
2898 |
§103§112 |
Non-Final OA |
— |
Pending |
May 07, 2024 |
| 18707117 |
PRIMED UTERINE-DERIVED REGENERATIVE CELL COMPOSITIONS AND USES THEREOF |
Gallant Pet, Inc. |
RAHMAN, MASUDUR |
1633 |
§103§112 |
Non-Final OA |
— |
Pending |
May 02, 2024 |
| 18653412 |
LOW COEFFICIENT OF THERMAL EXPANSION ALLOYS |
Carpenter Technology Corporation |
SU, XIAOWEI |
1733 |
§103§112 |
Non-Final OA |
— |
Pending |
May 02, 2024 |
| 18706441 |
Monoclonal Antibodies Against Carcinoembryonic Antigens, and Their Uses |
Mab Biotec, Inc. |
NICKOL, GARY B |
1642 |
DP |
Non-Final OA |
— |
Pending |
May 01, 2024 |
| 18251079 |
MODULATORS OF THE INTEGRATED STRESS PATHWAY |
AbbVie Inc. |
RAO, PADMAJA S |
1627 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Apr 28, 2024 |
| 18648288 |
METHODS AND SYSTEMS FOR ASSESSING HEMORRHOIDS AND TREATMENT EFFECTIVENESS THEREOF |
Citius Pharmaceuticals, Inc. |
LEE, ANDREW ELDRIDGE |
3684 |
§101§102§103 |
Final Rejection |
— |
Pending |
Apr 26, 2024 |
| 18704678 |
JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT |
UNIVERSITÄT BERN |
KIM, YOUNG J |
1681 |
§101§102§103§112 |
Non-Final OA |
— |
Pending |
Apr 25, 2024 |
| 18704267 |
METHODS OF TREATING ABNORMAL CELL GROWTH |
Verastem, Inc. |
ARCORIA, PAUL JOSEPH |
1621 |
§103§112 |
Non-Final OA |
— |
Pending |
Apr 24, 2024 |
| 18642140 |
METHOD AND SYSTEM FOR CONSISTENT, REPEATABLE, AND SAFE CRYOSPRAY TREATMENT OF AIRWAY TISSUE |
Csa Medical, Inc. |
PEFFLEY, MICHAEL F |
3794 |
§102§103 |
Final Rejection |
36d overdue |
Pending |
Apr 22, 2024 |
| 18640987 |
COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF |
Monte Rosa Therapeutics AG |
KOSTURKO, GEORGE W |
1621 |
§102DP |
Non-Final OA |
— |
Pending |
Apr 19, 2024 |
| 18637946 |
STERILE DISPOSABLE INTERFACES FOR PERCUTANEOUS INSTRUMENTS |
Mendaera, Inc. |
WALKER, OLIVIA |
3796 |
§102§103 |
Final Rejection |
12d |
Pending |
Apr 17, 2024 |
| 18634339 |
CHARGED AEROSOL DETECTORS |
Waters Technologies Corporation |
OLAMIT, JUSTIN N |
2853 |
§102§103§112 |
Final Rejection |
— |
Pending |
Apr 12, 2024 |
| 18701023 |
MODIFIED CELLS AND METHODS OF USE THEREOF |
New York Stem Cell Foundation, Inc. |
PRIEST, JESSICA MARIE |
1642 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Apr 12, 2024 |
| 18632667 |
DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS |
Neuroderm, Ltd. |
HUI, SAN MING R |
1627 |
§101DP |
Non-Final OA |
— |
Pending |
Apr 11, 2024 |
| 18699523 |
Compositions and Methods for Treating Cag Repeat Diseases |
BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY |
RYAN, DOUGLAS CHARLES |
1635 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Apr 08, 2024 |
| 18698443 |
ION DETECTORS |
Micromass UK Limited |
OSENBAUGH-STEWART, ELIZA W |
2881 |
§102§103§112 |
Final Rejection |
— |
Pending |
Apr 04, 2024 |
| 18620649 |
PROCESS FOR PURIFICATION OF PROTEIN |
Kashiv Biosciences, LLC |
HAQ, SHAFIQUL |
1678 |
§103 |
Final Rejection |
— |
Pending |
Mar 28, 2024 |
| 18696701 |
AN IMPROVED PROCESS FOR PURIFICATION OF FUSION PROTEIN |
Kashiv Biosciences, LLC |
KINGDON, CATHY |
1663 |
§103§112Other |
Final Rejection |
— |
Pending |
Mar 28, 2024 |
| 18615960 |
COMPOSITIONS AND METHODS FOR TARGETED DEPLETION, ENRICHMENT, AND PARTITIONING OF NUCLEIC ACIDS USING CRISPR/CAS SYSTEM PROTEINS |
Jumpcode Genomics, Inc. |
HIBBERT, CATHERINE S |
1658 |
§103§112DP |
Non-Final OA |
— |
Pending |
Mar 25, 2024 |
| 18694103 |
GLUCOSE MONITOR INJECTION PORT |
Insulet Corporation |
STIGELL, THEODORE J |
3783 |
§102§103 |
Final Rejection |
— |
Pending |
Mar 21, 2024 |
| 18612960 |
Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs |
Zymeworks, Inc. |
HUYNH, PHUONG N |
1641 |
§102§112 |
Final Rejection |
238d overdue |
Pending |
Mar 21, 2024 |
| 18693796 |
ION SOURCE ASSEMBLY |
Micromass UK Limited |
EINHORN, MICA JILLIAN |
2881 |
§103§112 |
Final Rejection |
— |
Pending |
Mar 20, 2024 |
| 18600948 |
ADHESIVE PAD WITH FEATURES TO AID APPLICATION AND HANDLING OF A MEDICAL DEVICE |
Insulet Corporation |
ABU-DAYEH, TAGWA MOHAMMAD |
3783 |
§103§112 |
Non-Final OA |
— |
Pending |
Mar 11, 2024 |
| 18601141 |
WIRELESS COMMUNICATION TAGS TO ENHANCE AID SYSTEM PERFORMANCE |
Insulet Corporation |
GARTLAND, SCOTT D |
3685 |
§101§102 |
Final Rejection |
14d |
Pending |
Mar 11, 2024 |
| 18600407 |
DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS |
Ensoma, Inc. |
SABILA, MERCY HELLEN |
1654 |
§102§103DP |
Non-Final OA |
— |
Pending |
Mar 08, 2024 |
| 18598289 |
PRODUCTION OF HEPATOCYTES |
Cambridge Enterprise Limited (Gb/Gb) |
GU, QINHUA |
1633 |
§103§112 |
Non-Final OA |
— |
Pending |
Mar 07, 2024 |
| 18593643 |
INDOLE COMPOUNDS AND METHODS OF USE |
Genzyme Corporation |
HEASLEY, MEGHAN CHRISTINE |
1626 |
§112 |
Non-Final OA |
— |
Pending |
Mar 01, 2024 |
| 18591704 |
CHROMAN DERIVATIVES HAVING ESTROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |
Accutar Biotechnology Inc. |
KOSACK, JOSEPH R |
3991 |
Other |
Non-Final OA |
— |
Pending |
Feb 29, 2024 |
| 18687692 |
ISOQUINOLINONES AND QUINOLINONES AS MODULATORS OF POLRMT |
Pretzel Therapeutics, Inc. |
SHAMEEM, GOLAM M |
1621 |
§102 |
Non-Final OA |
— |
Pending |
Feb 28, 2024 |
| 18687736 |
HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT |
Pretzel Therapeutics, Inc. |
ROBINSON, MIKHAIL O'DONNEL |
1627 |
§102§112 |
Non-Final OA |
— |
Pending |
Feb 28, 2024 |
| 18686737 |
SYSTEMS AND METHODS FOR INTEGRATING FIRE SAFETY FEATURES WITHIN ROBOTIC FURNITURE AND INTERIOR ARCHITECTURAL ELEMENTS |
Ori Inc. |
CAMERON, ATTICUS A |
3658 |
§103 |
Final Rejection |
— |
Pending |
Feb 26, 2024 |
| 18584998 |
PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS |
Kazusa Dna Research Institute |
LEE, JIA-HAI |
1658 |
§102§112DP |
Non-Final OA |
— |
Pending |
Feb 22, 2024 |
| 18444227 |
COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY |
Flagship Pioneering Innovations Vi, LLC |
DAUNER, JOSEPH G |
1682 |
§103§112 |
Final Rejection |
2d overdue |
Pending |
Feb 16, 2024 |
| 18683423 |
METHODS AND COMPOSITIONS FOR TREATING HYPERGLYCEMIA AND DIABETES |
Anagram Therapeutics, Inc. |
EIX, EMILY FAY |
1653 |
§101§102§103§112DP |
Non-Final OA |
— |
Pending |
Feb 13, 2024 |
| 18437678 |
CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE |
ETH ZÜRICH |
SKELDING, ZACHARY S |
1644 |
§112Other |
Non-Final OA |
— |
Pending |
Feb 09, 2024 |
| 18437804 |
MEDICAL DEVICE |
Arsenal Medical, Inc. |
GABR, MOHAMED GAMIL |
3771 |
§102 |
Non-Final OA |
— |
Pending |
Feb 09, 2024 |
| 18437595 |
SYSTEM AND METHOD FOR REDUCING CGM WARM-UP TIME BY APPLICATION OF OPTICAL ENERGY |
Insulet Corporation |
LIU, CHU CHUAN |
3791 |
§103 |
Final Rejection |
30d |
Pending |
Feb 09, 2024 |
| 18294893 |
PHRENIC NERVE PACING DEVICE |
Texas Heart Institute |
SAHAND, SANA |
3796 |
§103 |
Final Rejection |
— |
Pending |
Feb 02, 2024 |
| 18681014 |
ANALYTIC METHOD AND DEVICE FOR QUANTITATIVELY CALCULATING LINE EDGE ROUGHNESS IN PLASMA ULTRA-DIFFRACTION PHOTOETCHING PROCESS |
Institute Of Microelectronics, Chinese Academy Of Sciences |
WHITESELL, STEVEN H |
1759 |
§102§112 |
Final Rejection |
— |
Pending |
Feb 02, 2024 |
| 18294510 |
A PHARMACEUTICAL COMBINATION AND USE THEREOF |
Ascentage Pharma Group Corp Limited |
OH, TAYLOR V |
1625 |
§102§112 |
Non-Final OA |
— |
Pending |
Feb 01, 2024 |
| 18429539 |
SYSTEMS AND METHODS FOR INFERRING ENTITY RELATIONSHIPS VIA NETWORK COMMUNICATIONS OF USERS OR USER DEVICES |
Bitsight Technologies, Inc. |
RANDHAWA, MANDISH K |
2477 |
DP |
Final Rejection |
71d overdue |
Pending |
Feb 01, 2024 |
| 18292603 |
METHODS FOR SELECTING ANTIMICROBIALS AGAINST PHYTOPATHOGENS |
Organicin Scientific, Inc. |
ARIANI, KADE |
1651 |
§103 |
Final Rejection |
— |
Pending |
Jan 26, 2024 |
| 18421551 |
DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS |
Synedgen, Inc. |
LAU, JONATHAN S |
1693 |
§103DP |
Non-Final OA |
60d overdue |
Pending |
Jan 24, 2024 |
| 18416440 |
DEVICES AND METHODS FOR TREATING HEART FAILURE |
Corvia Medical, Inc. |
YANG, CHENG FONG |
3781 |
§103 |
Final Rejection |
— |
Pending |
Jan 18, 2024 |
| 18404740 |
CHROMAN DERIVATIVES HAVING ESTROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |
Accutar Biotechnology Inc. |
SANDERSON, LEE E |
3991 |
DP |
Non-Final OA |
— |
Pending |
Jan 04, 2024 |
| 18389888 |
METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS |
Deciphera Pharmaceuticals, LLC |
SZNAIDMAN, MARCOS L |
1628 |
§103 |
Non-Final OA |
— |
Pending |
Dec 20, 2023 |
| 18390450 |
CONTAINMENT, ACTIVATION, DEPLOYMENT, AND INTEGRATED FUNCTIONS OF FLEXIBLE, SLENDER ELEMENTS |
Insulet Corporation |
SMALE, AVERY E |
3783 |
§102§103 |
Final Rejection |
— |
Pending |
Dec 20, 2023 |
| 18571091 |
ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN yC DOMAIN AND METHODS OF USE |
Therini Bio, Inc. |
DARPOLOR, JOSEPHINE KEBBEH |
1642 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Dec 15, 2023 |
| 18541705 |
CHELATE COMPOUNDS |
GE Healthcare AS |
BAEK, JONGHWAN NMN |
1618 |
Other |
Non-Final OA |
— |
Pending |
Dec 15, 2023 |
| 18571170 |
SYSTEMS AND METHODS FOR INTERRUPTING NERVE ACTIVITY TO TREAT A MEDICAL CONDITION |
Texas Medical Center |
FLANAGAN, BEVERLY MEINDL |
3794 |
§102 |
Final Rejection |
33d |
Pending |
Dec 15, 2023 |
| 18541584 |
COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND FOLFIRINOX |
Fusion Pharmaceuticals Inc. |
BAEK, JONGHWAN NMN |
1618 |
§103Other |
Non-Final OA |
— |
Pending |
Dec 15, 2023 |
| 18541618 |
COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOX |
Fusion Pharmaceuticals Inc. |
DICKINSON, PAUL W |
1618 |
§101§103DP |
Non-Final OA |
— |
Pending |
Dec 15, 2023 |
| 18570579 |
Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications |
The United States Department of Health and Human Services |
DAVIS, BRIAN J |
1614 |
§102§112 |
Non-Final OA |
— |
Pending |
Dec 14, 2023 |
| 18538085 |
TUBE SET WITH DUAL PRESSURE REGULATING VALVE |
Rapid Micro Biosystems, Inc. |
WILLIAMS, PATRICK C |
1799 |
§102§103 |
Non-Final OA |
— |
Pending |
Dec 13, 2023 |
| 18569113 |
TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS |
Empirico Inc. |
VANHORN, ABIGAIL LOUISE |
1636 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Dec 11, 2023 |
| 18535291 |
HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS |
Sagimet Biosciences Inc. |
BORALSKY, LUKE ALAN |
1624 |
§103DP |
Non-Final OA |
— |
Pending |
Dec 11, 2023 |
| 18535441 |
METHOD, SYSTEM, AND APPARATUS FOR ANALYZING AN ANALYTE OF A SINGLE CELL |
Mission Bio, Inc. |
SALMON, KATHERINE D |
1682 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Dec 11, 2023 |
| 18569180 |
METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP |
GE Healthcare Limited |
SCHLIENTZ, LEAH H |
1618 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Dec 11, 2023 |
| 18568440 |
SUBCUTANEOUS FORMULATION AND METHODS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS |
Resq Pharmaceuticals LLC |
SAEED, ALI S |
1616 |
§103DP |
Non-Final OA |
— |
Pending |
Dec 08, 2023 |
| 18568694 |
NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES |
Nucleus Medical GmbH |
MERCIER, MELISSA S |
1615 |
§102§103§112 |
Final Rejection |
14d |
Pending |
Dec 08, 2023 |
| 18568165 |
VACUUM SYSTEM FOR A MASS SPECTROMETER |
Micromass UK Limited |
WANG, JING |
2881 |
§103 |
Non-Final OA |
38d overdue |
Pending |
Dec 07, 2023 |
| 18532424 |
Papain-like protease (PLpro) inhibitors |
Pfizer, Inc. |
BELL, SARA ELIZABETH |
1625 |
§102§112 |
Non-Final OA |
— |
Pending |
Dec 07, 2023 |
| 18567011 |
TREATMENT OF ANGPTL4 RELATED DISEASES |
Empirico Inc. |
ARIETI, RUTH SOPHIA |
1635 |
§102§103§112Other |
Non-Final OA |
— |
Pending |
Dec 04, 2023 |
| 18523044 |
LEAD SCREW WITHIN RESERVOIR |
Insulet Corporation |
ZAMORY, JUSTIN L |
3783 |
§102§112 |
Non-Final OA |
— |
Pending |
Nov 29, 2023 |
| 18519589 |
SOLID PHASE NEGATIVE ENRICHMENT |
Harbinger Health, Inc. |
HASAN, KHALEDA B |
1636 |
§103§112DP |
Non-Final OA |
— |
Pending |
Nov 27, 2023 |
| 18514724 |
CUTTING SUBASSEMBLY AND CONDITIONING ASSEMBLY FOR AN ENVIRONMENT |
Rapid Micro Biosystems, Inc. |
BOWERS, NATHAN ANDREW |
1799 |
§102§103§112 |
Final Rejection |
69d |
Pending |
Nov 20, 2023 |
| 18562768 |
BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION |
BELITE BIO, LLC |
RAHMANI, NILOOFAR |
1691 |
§102§112 |
Non-Final OA |
30d overdue |
Pending |
Nov 20, 2023 |
| 18508933 |
PRESSED AND MIXED THIN FILM ENZYMATIC REACTOR AND METHODS OF MAKING THE SAME |
Waters Technologies Corporation |
JONES-FOSTER, ERICA NICOLE |
1656 |
§103§112 |
Final Rejection |
22d |
Pending |
Nov 14, 2023 |
| 18504790 |
METHODS AND SYSTEMS FOR NON-BLOCKING TRANSACTIONS |
Cockroach Labs, Inc. |
FILIPCZYK, MARCIN R |
2153 |
§102Other |
Non-Final OA |
367d overdue |
Pending |
Nov 08, 2023 |
| 18504497 |
REDUCING JUNCTION EPITOPE PRESENTATION FOR NEOANTIGENS |
Gritstone Bio, Inc. |
GODDARD, LAURA B |
1642 |
§101§103§112DP |
Non-Final OA |
— |
Pending |
Nov 08, 2023 |
| 18503723 |
Microfluidic Devices for High Throughput Screening of Cell-Cell Interactions |
Shennon Biotechnologies Inc. |
CORDAS, EMILY ANN |
1632 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Nov 07, 2023 |
| 18559185 |
EXATECAN DERIVATIVES AND ANTIBODY-DRUG CONJUGATES THEREOF |
Alx Oncology Inc. |
AGUIRRE, AMANDA L |
1626 |
§103DP |
Non-Final OA |
— |
Pending |
Nov 06, 2023 |
| 18386647 |
PROGRAMMATIC MEDICAMENT TITRATION WITH A MEDICAMENT DELIVERY DEVICE |
Insulet Corporation |
SWANSON, LEAH JENNINGS |
3783 |
§103 |
Final Rejection |
14d |
Pending |
Nov 03, 2023 |
| 18386502 |
RECOMBINANT ALGAE HAVING HIGH BIOMASS AND LIPID PRODUCTIVITY |
Phykion Inc. |
JONES-FOSTER, ERICA NICOLE |
1656 |
§112 |
Final Rejection |
53d |
Pending |
Nov 02, 2023 |
| 18386435 |
METHODS AND MODELS FOR DIRECT MOLECULAR CONFORMATION GENERATION |
Chengdu Anticancer Bioscience, Ltd. |
ZEMAN, MARY K |
|
§101§102§103 |
Non-Final OA |
— |
Pending |
Nov 02, 2023 |
| 18499346 |
CHEMICAL MONITORING UNIT AND METHODS |
General Galactic Systems, Inc. |
MERCADO, ALEXANDER A |
2855 |
§103§112 |
Final Rejection |
34d |
Pending |
Nov 01, 2023 |
| 18498275 |
USE OF NON-INVASIVE GLUCOSE SENSORS AND GLUCOSE RATE OF CHANGE DATA IN AN INSULIN DELIVERY SYSTEM |
Insulet Corporation |
GOLLAMUDI, NEERAJA |
3783 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 31, 2023 |
| 18385649 |
BODILY FLUID TARGET ENRICHMENT |
Harbinger Health, Inc. |
HASAN, KHALEDA B |
1636 |
§103§112DP |
Non-Final OA |
— |
Pending |
Oct 31, 2023 |
| 18558139 |
PYRIDINO-OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF |
Zhejiang Genfleet Therapeutics Co., Ltd. |
SHTERENGARTS, SAMANTHA L |
1623 |
§102§112 |
Non-Final OA |
— |
Pending |
Oct 30, 2023 |
| 18557694 |
METHODS OF REGULATING BCL11A EXPRESSION AND TREATMENT OF BCL11A-MEDIATED DISORDERS |
Fulcrum Therapeutics, Inc. |
LEE, ANDREW P |
1691 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 27, 2023 |
| 18557408 |
GENE MODIFICATION QUANTIFICATION IN SINGLE-CELL SEQUENCING |
Mission Bio, Inc. |
AUGER, NOAH ANDREW |
1687 |
§101§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 26, 2023 |
| 18557528 |
ANALYTICAL HPLC |
GE Healthcare Limited |
BRAZIN, JACQUELINE |
1798 |
§102§103 |
Non-Final OA |
— |
Pending |
Oct 26, 2023 |
| 18494491 |
Self-Assembling Nanoparticles |
The United States Of America, AS Represented By The Secretary, Department Of Health |
VARADARAJ, ARCHANA |
1675 |
§112DP |
Non-Final OA |
— |
Pending |
Oct 25, 2023 |
| 18556409 |
NEBULISER OUTLET |
Micromass UK Limited |
STOFFA, WYATT A |
2881 |
§102§103§112 |
Non-Final OA |
5d |
Pending |
Oct 20, 2023 |
| 18490450 |
FN3 DOMAIN-SIRNA CONJUGATES AND USES THEREOF |
Aro Biotherapeutics Company |
RYAN, DOUGLAS CHARLES |
1635 |
§103 |
Non-Final OA |
— |
Pending |
Oct 19, 2023 |
| 18490413 |
COMPACT RATCHET MECHANISM |
Insulet Corporation |
KASHYAP, ESHA PRAKASH |
3783 |
§102§103 |
Non-Final OA |
— |
Pending |
Oct 19, 2023 |
| 18486830 |
MULTI-LEVEL INVERTER FOR WIRELESS POWER TRANSMISSION |
Witricity Corporation |
FINCH III, FRED E |
2838 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Oct 13, 2023 |
| 18379912 |
NON-VIRAL HOMOLOGY MEDIATED END JOINING |
Arsenal Biosciences, Inc. |
YU, DELPHINUS DOU YI |
1636 |
§103 |
Non-Final OA |
— |
Pending |
Oct 13, 2023 |
| 18555277 |
POMACE LEACHATE HERBICIDE COMPOSITION AND METHODS |
Jackson Family Wines, Inc. |
PEEBLES, KATHERINE |
1617 |
§101§102§103 |
Final Rejection |
4d overdue |
Pending |
Oct 13, 2023 |
| 18485766 |
ISOINDOLINONE COMPOUNDS |
Monte Rosa Therapeutics AG |
BARSKY, JARED |
1628 |
§112DP |
Non-Final OA |
— |
Pending |
Oct 12, 2023 |
| 18286045 |
MODIFIED GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AND CHIMERIC CYTOKINE RECEPTORS BINDING SAME |
UVIC INDUSTRY PARTNERSHIPS INC. |
GUSTILO, ESTELLA M |
1646 |
§102§103§112Other |
Final Rejection |
— |
Pending |
Oct 06, 2023 |
| 18553352 |
POLYMORPHIC FORMS OF (S)-12-FLUORO-4-(1-METHYL-1H-PYRAZOL-5-YL)-7A,8,13,14-TETRAHYDRO-7H-[1,2,4]TRIAZOLO[4',3':1,6]PYRIDO[3,2-B]BENZOFURO[4,3-FG][1,4]OXAZONINE |
Fulcrum Therapeutics, Inc. |
HAVLIN, ROBERT H |
1626 |
§102§103Other |
Final Rejection |
71d overdue |
Pending |
Sep 29, 2023 |
| 18553317 |
MACROCYCLIC AZOLOPYRIDINES |
Fulcrum Therapeutics, Inc. |
KENYON, JOHN S |
1625 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 29, 2023 |
| 17995096 |
APPLICATIONS OF P14K INHIBITOR IN INTRACELLULAR PROTEIN MISFOLDING-RELATED DISEASES AND LYSOSOMAL STORAGE DISEASES |
Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. |
CHONG, YONG SOO |
1623 |
§112 |
Final Rejection |
— |
Pending |
Sep 28, 2023 |
| 18477504 |
HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
University of Basel |
PERREIRA, MELISSA JEAN |
1618 |
§103 |
Final Rejection |
30d overdue |
Pending |
Sep 28, 2023 |
| 18474211 |
SOLID TARGET SYSTEMS FOR THE PRODUCTION OF HIGH-PURITY RADIONUCLIDE COMPOSITIONS |
Nuclidium AG |
CRAIG, KAILA ANGELIQUE |
1618 |
§103 |
Final Rejection |
— |
Pending |
Sep 25, 2023 |
| 18474060 |
COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY |
Flagship Pioneering Innovations Vi, LLC |
DAUNER, JOSEPH G |
1682 |
§103§112Other |
Non-Final OA |
70d |
Pending |
Sep 25, 2023 |
| 18471563 |
PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS |
Monte Rosa Therapeutics AG |
HASTINGS, ALISON AZAR |
1627 |
§103 |
Final Rejection |
6d |
Pending |
Sep 21, 2023 |
| 18551143 |
GENE THERAPIES FOR 21-HYDROXYLASE DEFICIENCY |
Adrenas Therapeutics, Inc. |
AMICK, THOMAS RUSSE |
1638 |
§102§112Other |
Non-Final OA |
49d |
Pending |
Sep 18, 2023 |
| 18369521 |
Application Of PI4KIIIA Protein And Related Membrane Protein Complex In Treating Alzheimer's Disease |
Jiangsu Nuo-Beta Pharmaceutical Technology Co., Ltd. |
WEIDNER, ADAM M |
1675 |
§112Other |
Final Rejection |
— |
Pending |
Sep 18, 2023 |
| 18550920 |
NOVEL FORMULATION OF FUSION PROTEIN |
Kashiv Biosciences, LLC |
CHANDRA, GYAN |
1674 |
§103§112 |
Non-Final OA |
— |
Pending |
Sep 15, 2023 |
| 18368931 |
METHODS, SYSTEMS, AND ARRAYS FOR BIOMOLECULAR ANALYSIS |
Vibrant Holdings, LLC |
BROWN, MINDY G |
1634 |
DP |
Final Rejection |
— |
Pending |
Sep 15, 2023 |
| 18282254 |
PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF |
Zhejiang Genfleet Therapeutics Co., Ltd. |
HEASLEY, MEGHAN CHRISTINE |
1626 |
§102 |
Non-Final OA |
56d |
Pending |
Sep 15, 2023 |
| 18466639 |
SYSTEMS AND METHODS FOR USING MICROBIAL MEASUREMENTS TO DERIVE FINANCIAL PRODUCTS |
Ancera Inc. |
KALLAL, ROBERT JAMES |
1685 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Sep 13, 2023 |
| 18466217 |
MECHANISM PROVIDING VARIABLE FILL CAPABILITY FOR A LIQUID RESERVOIR AND PUMP |
Insulet Corporation |
LAZO, THOMAS E |
3745 |
§102§112 |
Non-Final OA |
— |
Pending |
Sep 13, 2023 |
| 18464519 |
METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS |
Deciphera Pharmaceuticals, LLC |
VALENROD, YEVGENY |
1628 |
§103 |
Final Rejection |
24d overdue |
Pending |
Sep 11, 2023 |
| 18463880 |
COMPUTING ARCHITECTURE FOR TRANSACTION AUTHORIZATION AND MEDIUMS AND METHODS FOR THE SAME |
Perpay Inc. |
JUNG, HENRY H |
3695 |
§101§102§103 |
Final Rejection |
— |
Pending |
Sep 08, 2023 |
| 18464035 |
MULTIPLE-TIERED SCREENING AND SECOND ANALYSIS |
Flagship Pioneering Innovations Vi, LLC |
LIN, JERRY |
1685 |
§101§103§112DP |
Non-Final OA |
— |
Pending |
Sep 08, 2023 |
| 18027275 |
ELECTROCHEMICAL SYSTEMS AND METHODS |
Massachusetts Institute Of Technology |
RUFO, LOUIS J |
1795 |
§112 |
Non-Final OA |
— |
Pending |
Sep 08, 2023 |
| 18463183 |
MODULATORS OF THE INTEGRATED STRESS PATHWAY |
AbbVie Inc. |
O DELL, DAVID K |
1621 |
§103DP |
Non-Final OA |
— |
Pending |
Sep 07, 2023 |
| 18549452 |
STABILIZED LIQUID COMPOSITIONS COMPRISING A LEVODOPA-TYROSINE CONJUGATE AND USES THEREOF |
Neuroderm, Ltd. |
CHO, DAVID H |
1693 |
§102§103§112Other |
Non-Final OA |
22d |
Pending |
Sep 07, 2023 |
| 18462918 |
MODULATORS OF THE INTEGRATED STRESS PATHWAY |
AbbVie Inc. |
NOLAN, JASON MICHAEL |
1623 |
Other |
Final Rejection |
118d overdue |
Pending |
Sep 07, 2023 |
| 18461179 |
INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF |
Pardes Biosciences, Inc. |
MCDOWELL, BRIAN E |
1624 |
— |
Non-Final OA |
71d overdue |
Pending |
Sep 05, 2023 |
| 18279938 |
ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES |
UNIVERSITY OF MARYLAND, BALTIMORE |
NICKOL, GARY B |
1643 |
§112 |
Final Rejection |
7d |
Pending |
Sep 01, 2023 |
| 18240823 |
DEVICES FOR COLLECTING CAPILLARY BLOOD AND METHODS FOR SAME |
Paulus Holdings Limited |
PORTILLO, JAIRO H |
3791 |
§103DP |
Final Rejection |
45d overdue |
Pending |
Aug 31, 2023 |
| 18240423 |
METHOD FOR DETECTING OCCLUSIONS IN A FLUID PATH USING BLOOD GLUCOSE READINGS |
Insulet Corporation |
ALVARADO JR, NELSON LOUIS |
3783 |
§101 |
Final Rejection |
4d overdue |
Pending |
Aug 31, 2023 |
| 18454323 |
SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY TO ACCOUNT FOR INSULIN RESISTANCE |
Insulet Corporation |
GONZALEZ, LEI NMN |
3783 |
§102§103 |
Final Rejection |
26d |
Pending |
Aug 23, 2023 |
| 18547207 |
REVERSIBLE TERMINATORS |
Ansa Biotechnologies, Inc. |
RILEY, JEZIA |
1681 |
§102§112 |
Non-Final OA |
— |
Pending |
Aug 21, 2023 |
| 18451530 |
USE OF LOGARITHMIC TRANSFORM/FILTER TO IMPROVE OPERATION OF MEDICAMENT DELIVERY DEVICE |
Insulet Corporation |
NEWTON, CHAD A |
3681 |
§102 |
Non-Final OA |
— |
Pending |
Aug 17, 2023 |
| 18450238 |
SAFETY AND ACCURACY MEASURES FOR MEDICAMENT BOLUS DELIVERY |
Insulet Corporation |
PATEL, SHEFALI DILIP |
3783 |
§102§103§112 |
Final Rejection |
— |
Pending |
Aug 15, 2023 |
| 18450081 |
ADHESIVE LAYER WITH MULTIPLE STRENGTHS OF ADHESIVES FOR SECURING AN ON-BODY MEDICAL DEVICE TO A USER |
Insulet Corporation |
STIMPERT, PHILIP EARL |
3783 |
§102§103 |
Final Rejection |
— |
Pending |
Aug 15, 2023 |
| 18546528 |
ION SOURCE NEBULISER |
Micromass UK Limited |
KALISZEWSKI, ALINA ROSE |
2881 |
§101§103 |
Non-Final OA |
— |
Pending |
Aug 15, 2023 |
| 18277220 |
Self-Assembling Nanoparticles Based On Amphiphilic Peptides |
The United States Department of Health and Human Services |
VARADARAJ, ARCHANA |
1658 |
§103§112DP |
Non-Final OA |
— |
Pending |
Aug 14, 2023 |
| 18448385 |
APPARATUS AND METHOD FOR REDUCTION OF NEUROLOGICAL MOVEMENT DISORDER SYMPTOMS USING WEARABLE DEVICE |
Encora, Inc. |
RAUBENSTRAW, TYLER ALLEN |
3785 |
§103Other |
Final Rejection |
27d |
Pending |
Aug 11, 2023 |
| 18447656 |
SYSTEM AND METHOD FOR APPLYING VIBRATORY STIMULUS IN A WEARABLE DEVICE |
Encora, Inc. |
MILLER, CHRISTOPHER E |
3785 |
§103 |
Final Rejection |
— |
Pending |
Aug 10, 2023 |
| 18276527 |
COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF |
Elevatebio Technologies, Inc. |
COLEMAN, BRENDA LIBBY |
1624 |
§102§112 |
Final Rejection |
40d |
Pending |
Aug 09, 2023 |
| 18264217 |
A METHOD OF ANALYSIS OF MASS SPECTROMETRY DATA |
Waters Technologies Ireland Limited |
NGHIEM, MICHAEL P |
2857 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Aug 03, 2023 |
| 18263820 |
COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH |
Verastem, Inc. |
SEITZ, ANTHONY JOSEPH |
1629 |
§102§103 |
Non-Final OA |
— |
Pending |
Aug 01, 2023 |
| 18275199 |
SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY |
Octant, Inc. |
PAK, MICHAEL D |
1644 |
§101§102§112Other |
Non-Final OA |
— |
Pending |
Jul 31, 2023 |
| 18359183 |
SYSTEMS AND METHODS FOR ASSESSING CYBERSECURITY EFFICACY OF ENTITIES AGAINST COMMON CONTROL AND MATURITY FRAMEWORKS USING EXTERNALLY-OBSERVED DATASETS |
Bitsight Technologies, Inc. |
HAJIABBASI, AMIR MAHDI |
2407 |
§103 |
Non-Final OA |
— |
Pending |
Jul 26, 2023 |
| 18356925 |
TISSUE PENETRATING AND BIODEGRADABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF |
Panther Therapeutics, Inc. |
GOTFREDSON, GAREN |
1619 |
§102§103§112Other |
Final Rejection |
— |
Pending |
Jul 21, 2023 |
| 18355913 |
HIGH MOLYBDENUM DUPLEX STAINLESS STEEL |
Carpenter Technology Corporation |
HILL, STEPHANI A |
1735 |
§103 |
Final Rejection |
— |
Pending |
Jul 20, 2023 |
| 18262318 |
METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE |
Kashiv Biosciences, LLC |
ROBINSON, HOPE A |
1652 |
§102§103§112 |
Final Rejection |
24d overdue |
Pending |
Jul 20, 2023 |
| 18272087 |
HOMOLOGOUS ADENOVIRAL VACCINATION |
Gritstone Bio, Inc. |
GRIZER, CASSANDRA SENN |
1672 |
§103§112 |
Non-Final OA |
— |
Pending |
Jul 12, 2023 |
| 18350223 |
INFORMING A USER OF ANTICIPATED INSULIN DELIVERY ACTIONS AND PROVIDING RECOMMENDED USER ACTIONS |
Insulet Corporation |
KASHYAP, ESHA PRAKASH |
3783 |
§102§103 |
Non-Final OA |
— |
Pending |
Jul 11, 2023 |
| 18342951 |
SYSTEM AND METHOD FOR DETECTING OCCLUSIONS IN A FLUID PATH |
Insulet Corporation |
BOSWORTH, KAMI A |
3783 |
§102§103§112 |
Final Rejection |
7d |
Pending |
Jun 28, 2023 |
| 18269301 |
METHODS OF TREATING MULTIPLE SCLEROSIS |
Ascentage Pharma Group Corp Limited |
SHIM, DAVID M. |
1626 |
§103 |
Final Rejection |
51d overdue |
Pending |
Jun 23, 2023 |
| 18340339 |
WEARABLE DRUG DELIVERY DEVICE WITH INCORPORATED FILTRATION |
Insulet Corporation |
ZAMORY, JUSTIN L |
3783 |
§102§103 |
Non-Final OA |
— |
Pending |
Jun 23, 2023 |
| 18259015 |
MASS AND/OR ION MOBILITY SPECTROMETRY |
Micromass UK Limited |
NGUYEN, KIET TUAN |
2881 |
§103 |
Final Rejection |
— |
Pending |
Jun 22, 2023 |
| 18258399 |
METHOD OF CONTROLLING A JOINT OF AN ORTHOPAEDIC TECHNOLOGY DEVICE AND JOINT OF THIS KIND |
Ottobock SE & Co. Kgaa |
NERENBERG, RENEE FLORENCIA |
3774 |
§102§103 |
Final Rejection |
43d overdue |
Pending |
Jun 20, 2023 |
| 18335103 |
ALL-SUTURE ANCHOR |
Responsive Arthroscopy, Inc. |
HOLWERDA, KATHLEEN SONNETT |
3771 |
§102§103§112 |
Non-Final OA |
45d overdue |
Pending |
Jun 14, 2023 |
| 18334243 |
SIMULATION SOFTWARE PLATFORM FOR MEMRISTIVE NANOWIRE NETWORKS |
Emergentia, Inc. |
COCCHI, MICHAEL EDWARD |
2188 |
§103§112 |
Non-Final OA |
— |
Pending |
Jun 13, 2023 |
| 18257045 |
FROZEN PLANT-BASED PORTIONED MILK CONCENTRATE AND METHODS OF PREPARATION THEREOF |
Daily Harvest, Inc. |
AXTELL, ASHLEY |
1792 |
§103§112 |
Non-Final OA |
42d |
Pending |
Jun 12, 2023 |
| 18255539 |
COMPOSITIONS AND METHODS OF USE THEREOF |
Gritstone Bio, Inc. |
JADHAO, SAMADHAN JAISING |
1672 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
Jun 01, 2023 |
| 18203919 |
Controllable Transcription |
Cambridge Enterprise Limited (Gb/Gb) |
KONOPKA, CATHERINE ANNE |
1635 |
§103§112Other |
Non-Final OA |
— |
Pending |
May 31, 2023 |
| 18037959 |
TREATMENT OF SOS2 RELATED DISEASES AND DISORDERS |
Empirico Inc. |
YU, DAVID TUYANG |
1635 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
May 19, 2023 |
| 18199476 |
CUSTOMIZATION OF A GLUCOSE PREDICTION MODEL FOR A USER IN AN AUTOMATED INSULIN DELIVERY (AID) DEVICE |
Insulet Corporation |
LANGE, ERIC A |
3783 |
§102§103§112 |
Non-Final OA |
13d |
Pending |
May 19, 2023 |
| 18037960 |
GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY |
Empirico Inc. |
VANHORN, ABIGAIL LOUISE |
1636 |
§103§112 |
Non-Final OA |
— |
Pending |
May 19, 2023 |
| 18199638 |
SWITCHING AND CUSTOMIZATION OF GLUCOSE PREDICTION MODELS IN MEDICAMENT DELIVERY DEVICES |
Insulet Corporation |
SHAH, NILAY J |
3783 |
§112 |
Final Rejection |
— |
Pending |
May 19, 2023 |
| 18037515 |
FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS |
BEXSON BIOMEDICAL, INC. |
VISHNYAKOVA, ELENA VLADIMIROVNA |
1691 |
§102Other |
Non-Final OA |
— |
Pending |
May 17, 2023 |
| 18037063 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTESTINAL CANCER |
UNITED KINGDOM RESEARCH AND INNOVATION |
OUSPENSKI, ILIA I |
1644 |
§102§103§112DP |
Non-Final OA |
— |
Pending |
May 15, 2023 |
| 18316851 |
SYSTEMS AND METHODS FOR TRANSACTION COMMIT AND LOCK RELEASE ATOP PARTITIONED CONSENSUS |
Cockroach Labs, Inc. |
ADAMS, CHARLES D |
2152 |
§103 |
Non-Final OA |
84d |
Pending |
May 12, 2023 |
| 18313767 |
INSTRUMENT FOR A MEDICAMENT DELIVERY DEVICE THAT ACTS AS NEEDLE AND CANNULA |
Insulet Corporation |
MEDWAY, SCOTT J |
3783 |
§102§103§112 |
Non-Final OA |
86d |
Pending |
May 08, 2023 |
| 18143848 |
SYSTEM AND METHOD FOR LASER BASED ENDODONTIC TREATMENT |
Convergent Dental, Inc. |
HOLTZCLAW, MICHAEL T. |
3796 |
§103 |
Final Rejection |
23d |
Pending |
May 05, 2023 |
| 18308481 |
COMPOSITIONS AND METHODS OF GENOMIC MODIFICATION OF CELLS AND USES THEREOF |
Arsenal Biosciences, Inc. |
YU, DAVID TUYANG |
1635 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Apr 27, 2023 |
| 18250347 |
RECOMBINANT T-CELL RECEPTORS THAT BIND THE NY-ESO-1 AND/OR LAGE-1A CANCER ANTIGENS |
T-Cure Bioscience, Inc. |
BRISTOL, LYNN ANNE |
1643 |
§112Other |
Non-Final OA |
28d |
Pending |
Apr 24, 2023 |
| 18033470 |
METHODS FOR PROCESSING FETAL SUPPORT TISSUE |
BIOTISSUE HOLDINGS INC. |
PAULUS, ERIN VIRGINIA |
1631 |
§103 |
Final Rejection |
27d |
Pending |
Apr 24, 2023 |
| 18305755 |
APPARATUS FOR CONTROLLED ENVIRONMENT ESTABLISHMENT, MAINTENANCE, AND SAMPLING |
BIOCONSORTIA, INC. |
CARREON, ADRIAN JOHN |
1799 |
§103 |
Non-Final OA |
— |
Pending |
Apr 24, 2023 |
| 18306041 |
COMPRESSION DETECTION AND COMPENSATION FOR A BIOLOGICAL SENSOR SECURED TO A USER |
Insulet Corporation |
GONZALEZ, LEI NMN |
3783 |
§102§103 |
Final Rejection |
58d overdue |
Pending |
Apr 24, 2023 |
| 18302925 |
SYSTEMS AND METHODS FOR EXTERNAL DETECTION OF MISCONFIGURED SYSTEMS |
Bitsight Technologies, Inc. |
KORSAK, OLEG |
2492 |
DP |
Non-Final OA |
17d overdue |
Pending |
Apr 19, 2023 |
| 18032538 |
Star Polymer Drug Conjugates |
The United States Department of Health and Human Services |
LISTVOYB, GREGORY |
1765 |
§102§103 |
Non-Final OA |
— |
Pending |
Apr 18, 2023 |
| 18131634 |
SOLID PHASE NEGATIVE ENRICHMENT |
Harbinger Health, Inc. |
HASAN, KHALEDA B |
1636 |
§103DP |
Non-Final OA |
— |
Pending |
Apr 06, 2023 |
| 18028992 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES |
Empirico Inc. |
WHITEMAN, BRIAN A |
1636 |
DP |
Final Rejection |
30d |
Pending |
Mar 28, 2023 |
| 18246783 |
METHOD FOR CONTROLLING A PROSTHETIC FOOT |
Otto Bock Healthcare Products GmbH |
BAHENA, CHRISTIE L. |
3774 |
§103 |
Final Rejection |
28d overdue |
Pending |
Mar 27, 2023 |
| 18190572 |
AUTONOMOUS ADAPTIVITY AND SET POINT CONTROL FOR A DRUG DELIVERY DEVICE |
Insulet Corporation |
THOMAN, EVELYN ANNE |
3783 |
§103§112 |
Non-Final OA |
— |
Pending |
Mar 27, 2023 |
| 18187792 |
PROGRAMMATIC PROCESSING OF PROTEIN OR NUCLEIC ACID SEQUENCES TO IDENTIFY MUTATIONS AT PROGRAMMATICALLY DETERMINED SUBSEQUENCES |
Waters Technologies Ireland Limited |
SMITH, JENNIFER JOY |
1685 |
§101§102§103§112 |
Non-Final OA |
— |
Pending |
Mar 22, 2023 |
| 18027346 |
Compositions and Methods of Manufacturing Amphiphilic Block Copolymers that Form Nanoparticles in Situ |
Institute Of Macromolecular Chemistry |
ZHANG SPIERING, DONGXIU |
1616 |
§103§112 |
Final Rejection |
26d |
Pending |
Mar 20, 2023 |
| 18121328 |
BODILY FLUID TARGET ENRICHMENT |
Harbinger Health, Inc. |
HASAN, KHALEDA B |
1636 |
§103§112DP |
Non-Final OA |
— |
Pending |
Mar 14, 2023 |
| 18181386 |
CONTROL ELEMENTS FOR TRACKING AND MOVEMENT OF FURNITURE AND INTERIOR ARCHITECTURAL ELEMENTS |
Ori Inc. |
SHAFAYET, MOHAMMED |
2116 |
§103 |
Non-Final OA |
— |
Pending |
Mar 09, 2023 |
| 18177284 |
CHARACTERIZING FUNCTIONAL REGULATORY ELEMENTS USING MACHINE LEARNING |
Camp4 Therapeutics Corporation |
BAILEY, STEVEN WILLIAM |
1687 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Mar 02, 2023 |
| 18176969 |
SINGLE PACKAGE AUTOMATED DRUG DELIVERY SYSTEM |
Insulet Corporation |
WHITROCK, ZACHARIAH KIRBY |
3783 |
§103 |
Final Rejection |
36d |
Pending |
Mar 01, 2023 |
| 18024149 |
Biomarkers for Predicting Multiple Sclerosis Disease Progression |
Octave Bioscience, Inc. |
BOWERS, ERIN M |
1653 |
§101§103§112DP |
Non-Final OA |
— |
Pending |
Mar 01, 2023 |
| 18023668 |
Storage Stable Films Comprising Fibrin and/or Fibrinogen |
Octapharma AG |
MATTISON, LORI K |
1619 |
§103§112 |
Non-Final OA |
34d |
Pending |
Feb 27, 2023 |
| 18173049 |
INTRA-INDIVIDUAL ANALYSIS FOR PRESENCE OF HEALTH CONDITIONS |
Flagship Pioneering Innovations Vi, LLC |
TURPIN, ZACHARY MARK |
1682 |
§101DP |
Final Rejection |
— |
Pending |
Feb 22, 2023 |
| 18042375 |
NEBULIZER DEVICE OPTIMIZATION FOR IMPROVED AEROSOL PARAMETERS AND USES THEREOF |
Avalyn Pharma Inc. |
PINDERSKI, JACQUELINE M |
3785 |
§103§112 |
Final Rejection |
104d overdue |
Pending |
Feb 21, 2023 |
| 18171930 |
NEBULIZER DEVICE OPTIMIZATION FOR IMPROVED AEROSOL PARAMETERS AND USES THEREOF |
Avalyn Pharma Inc. |
PINDERSKI, JACQUELINE M |
3785 |
§103 |
Final Rejection |
96d overdue |
Pending |
Feb 21, 2023 |
| 18042193 |
A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS |
UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD |
RYAN, DOUGLAS CHARLES |
1635 |
§103§112DP |
Final Rejection |
3d overdue |
Pending |
Feb 17, 2023 |
| 18111511 |
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE |
Servier Pharmaceuticals LLC |
KOMATSU, LI N |
1658 |
DP |
Non-Final OA |
— |
Pending |
Feb 17, 2023 |
| 18040933 |
STABLE CELL LINES FOR SITE-SPECIFIC INCORPORATION OF UNNATURAL AMINO ACIDS |
Brickbio, Inc. |
POPA, ILEANA |
1633 |
§103§112Other |
Non-Final OA |
— |
Pending |
Feb 07, 2023 |
| 18106443 |
SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS |
Vibrant Holdings, LLC |
BUNKER, AMY M |
1684 |
§103 |
Final Rejection |
— |
Pending |
Feb 06, 2023 |
| 18164392 |
MODULAR PRE-LOADED MEDICAL IMPLANTS AND DELIVERY SYSTEMS |
Cardiac Dimensions Pty. Ltd. |
MANNAN, MIKAIL A |
3774 |
§103§112Other |
Non-Final OA |
21d |
Pending |
Feb 03, 2023 |
| 18163451 |
MACHINE LEARNING TECHNIQUES FOR DISCOVERING ERRORS AND SYSTEM READINESS CONDITIONS IN LIQUID CHROMATOGRAPHY INSTRUMENTS |
Waters Technologies Ireland Limited |
HAMMOND III, THOMAS M |
2855 |
§101§102§103§112Other |
Non-Final OA |
70d |
Pending |
Feb 02, 2023 |
| 18163196 |
CAPTURE OF NUCLEIC ACIDS USING A NUCLEIC ACID-GUIDED NUCLEASE-BASED SYSTEM |
Jumpcode Genomics, Inc. |
BERTAGNA, ANGELA MARIE |
1681 |
§103§112 |
Non-Final OA |
— |
Pending |
Feb 01, 2023 |
| 18160724 |
EVENT DETECTION FOR DRUG DELIVERY SYSTEM |
Insulet Corporation |
GOLLAMUDI, NEERAJA |
3783 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Jan 27, 2023 |
| 18159300 |
ACCELERATOR FOR MULTI-PASS MASS SPECTROMETERS |
Micromass UK Limited |
LOGIE, MICHAEL J |
2881 |
§112 |
Final Rejection |
— |
Pending |
Jan 25, 2023 |
| 18157394 |
METHODS AND SYSTEMS FOR PRESSURE-BASED FLUID CONTROL IN A FLUID DELIVERY SYSTEM |
Insulet Corporation |
NORTH, ISABELLA SARAH HYO SO |
3783 |
§103§112 |
Final Rejection |
4d overdue |
Pending |
Jan 20, 2023 |
| 18006243 |
SUPERANTIGEN CONJUGATE FOR USE IN METHODS AND COMPOSITIONS FOR TREATING CANCER |
Neotx Therapeutics Ltd. |
JACKSON-TONGUE, LAKIA J |
1645 |
§102§112 |
Non-Final OA |
— |
Pending |
Jan 20, 2023 |
| 18156687 |
Pain Medicine Combination and Uses Thereof |
Mindlab, LLC |
CHONG, YONG SOO |
1623 |
§103 |
Final Rejection |
— |
Pending |
Jan 19, 2023 |
| 18016827 |
ORTHOPAEDIC JOINT DEVICE |
Otto Bock Healthcare Products GmbH |
BAHENA, CHRISTIE L. |
3774 |
§102§103§112 |
Non-Final OA |
21d |
Pending |
Jan 18, 2023 |
| 18016838 |
METHOD FOR CONTROLLING A PROSTHESIS OR ORTHOSIS |
Otto Bock Healthcare Products GmbH |
BAHENA, CHRISTIE L. |
3774 |
§103 |
Final Rejection |
35d overdue |
Pending |
Jan 18, 2023 |
| 18016831 |
METHOD FOR CONTROLLING A PROSTHESIS OR ORTHESIS |
Otto Bock Healthcare Products GmbH |
SPENCER, MAXIMILIAN TOBIAS |
3774 |
§101 |
Non-Final OA |
33d |
Pending |
Jan 18, 2023 |
| 18014862 |
INFUSION PUMP DEPLOYMENT SYSTEMS AND METHODS |
Insulet Corporation |
PONTON, JAMES D |
3783 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Jan 06, 2023 |
| 18004589 |
FILTRATION ASSEMBLIES, CASSETTES, SYSTEMS, AND METHODS FOR FILTRATION AND CELL GROWTH |
Rapid Micro Biosystems, Inc. |
SHI, TINGCHEN |
1796 |
§103 |
Non-Final OA |
61d |
Pending |
Jan 06, 2023 |
| 18004151 |
COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA |
Elevatebio Technologies, Inc. |
ROGERS, ERIC JASON |
1638 |
§102§103§112DP |
Final Rejection |
7d |
Pending |
Jan 03, 2023 |
| 18092544 |
POLYPEPTIDES, VACCINE COMPOSITIONS, AND USE THEREOF FOR INDUCING IMMUNE RESPONSE TO SARS-COV-2 IN PRIMATES |
Kang Zhang |
QIAN, CELINE X |
1637 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Jan 03, 2023 |
| 18089372 |
SYSTEM AND METHOD FOR LASER BASED WHITENING TREATMENT OF HARD TISSUE |
Convergent Dental, Inc. |
BELK, SHANNEL NICOLE |
3772 |
§103 |
Final Rejection |
— |
Pending |
Dec 27, 2022 |
| 18003234 |
RECOMBINANT SIALIDASES WITH REDUCED PROTEASE SENSITIVITY, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME |
Palleon Pharmaceuticals Inc. |
GODDARD, LAURA B |
1642 |
§102§112DP |
Non-Final OA |
— |
Pending |
Dec 23, 2022 |
| 18145772 |
SARS-COV-2 SERUM ANTIBODY PROFILING |
Serimmune Inc. |
ZOU, NIANXIANG |
1671 |
§102§103§112 |
Non-Final OA |
162d overdue |
Pending |
Dec 22, 2022 |
| 18085792 |
THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE |
Verastem, Inc. |
JAVANMARD, SAHAR |
1622 |
§103§112Other |
Final Rejection |
142d overdue |
Pending |
Dec 21, 2022 |
| 18001898 |
PARALLEL ANALYSIS OF INDIVIDUAL CELLS FOR RNA EXPRESSION AND DNA FROM TARGETED TAGMENTATION BY SEQUENCING |
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD |
PHAM, KHAI QUYNH TIEN |
1684 |
§103 |
Non-Final OA |
— |
Pending |
Dec 15, 2022 |
| 18078240 |
INTERTUMORAL HOMOGENEITY DETERMINED BY MiCK ASSAY |
Pierian Biosciences, LLC |
BAEK, JONGHWAN NMN |
1618 |
§101§103§112Other |
Non-Final OA |
6d |
Pending |
Dec 09, 2022 |
| 17928708 |
TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF GENE TRANSCRIPTS |
Quralis Corporation |
SHIN, DANA H |
1635 |
§112 |
Final Rejection |
80d overdue |
Pending |
Nov 30, 2022 |
| 18059170 |
CAPACITANCE SENSING FOR COMPONENT POSITIONING DETECTION |
Insulet Corporation |
BOBISH, CHRISTOPHER S |
3746 |
§103 |
Final Rejection |
16d |
Pending |
Nov 28, 2022 |
| 17923421 |
ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE |
Angarus Therapeutics, Inc. |
JARRELL, NOBLE E |
1699 |
§112 |
Final Rejection |
86d overdue |
Pending |
Nov 22, 2022 |
| 17989006 |
METHODS AND COMPOSITIONS FOR TREATING ABNORMAL CELL GROWTH |
Verastem, Inc. |
JAVANMARD, SAHAR |
1622 |
§103§112DP |
Final Rejection |
— |
Pending |
Nov 17, 2022 |
| 17998012 |
AN ATMOSPHERIC PRESSURE IONISATION SOURCE |
Micromass UK Ltd. |
KALISZEWSKI, ALINA ROSE |
2881 |
§103 |
Non-Final OA |
— |
Pending |
Nov 04, 2022 |
| 17921509 |
METHODS OF TREATING ABNORMAL CELL GROWTH |
Verastem, Inc. |
HIRAKIS, SOPHIA P |
1623 |
§103 |
Non-Final OA |
— |
Pending |
Oct 26, 2022 |
| 18048747 |
DUAL TARGETED IMMUNE REGULATING COMPOSITIONS |
Seismic Therapeutic, Inc. |
MOSELEY II, NELSON B |
1642 |
§103DP |
Non-Final OA |
— |
Pending |
Oct 21, 2022 |
| 18048407 |
CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF |
Gritstone Bio, Inc. |
LEE, HOI YAN NMN |
1693 |
§103Other |
Final Rejection |
31d overdue |
Pending |
Oct 20, 2022 |
| 17996599 |
CALIBRATION OF ANALYTICAL INSTRUMENT |
Micromass UK Limited |
STOFFA, WYATT A |
2800 |
§101§102 |
Non-Final OA |
— |
Pending |
Oct 19, 2022 |
| 17995657 |
SYSTEM FOR DELIVERING TARGETED CONTENT WITH CARE PREFERENCE SUGGESTIONS |
Texas Medical Center |
KANAAN, LIZA TONY |
3683 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Oct 06, 2022 |
| 17995098 |
AN ELECTRIC FIELD OR ELECTRIC VOLTAGE DELIVERING ELECTRODE SYSTEM FOR THE TREATMENT OF INTERNAL ORGAN OEDEMA |
Berlin Heals GmbH |
SIRCAR, ALISHA JITENDRA |
3792 |
§112 |
Non-Final OA |
— |
Pending |
Sep 29, 2022 |
| 17914691 |
METHODS OF USING UMBILICAL CORD PRODUCTS FOR TREATMENT OF OCULAR SURFACE DISORDERS |
BIOTISSUE HOLDINGS INC. |
MOSS, NATALIE M |
1653 |
§103 |
Non-Final OA |
— |
Pending |
Sep 26, 2022 |
| 17934950 |
PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION |
Kashiv Biosciences, LLC |
COOK, LISA V |
1641 |
DP |
Non-Final OA |
59d overdue |
Pending |
Sep 23, 2022 |
| 17932845 |
METHODS, MEDIUMS, AND SYSTEMS FOR ESTABLISHING A QUALITY CONTROL RECORD CHAIN FOR LABORATORY ANALYTICAL INSTRUMENTS |
Waters Technologies Ireland Limited |
LESNIEWSKI, VICTOR D |
2493 |
§103 |
Final Rejection |
26d |
Pending |
Sep 16, 2022 |
| 17821989 |
COMPENSATING FOR CHANGES IN POTENCY OF A MEDICAMENT IN A MEDICAMENT DELIVERY DEVICE |
Insulet Corporation |
BOSWORTH, KAMI A |
3783 |
§112 |
Final Rejection |
— |
Pending |
Aug 24, 2022 |
| 17800958 |
METHODS AND COMPOSITIONS FOR MODULATING ARGININE LEVELS IN IMMUNE CELLS |
Sky Perfect International Limited |
DHAR, MATASHA |
1632 |
§101§102§103§112 |
Final Rejection |
147d overdue |
Pending |
Aug 19, 2022 |
| 17904089 |
ENGINEERED FLUORESCENT SPONTANEOUS ISOMERIZATION RATE BIOSENSORS |
Calico Life Sciences LLC |
TRAN, CHAU NGUYEN BICH |
1677 |
§102§103Other |
Final Rejection |
— |
Pending |
Aug 11, 2022 |
| 17904038 |
BIO-THERAPEUTICS FOR DETECTION, DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH MUCOSAL BLEEDING |
Tenza, Inc. |
JOHANSEN, PETER N. |
1644 |
§102§103§112 |
Non-Final OA |
21d |
Pending |
Aug 11, 2022 |
| 17817312 |
HIV ANTIGENS AND MHC COMPLEXES |
Gritstone Bio, Inc. |
LIPPOLIS, ALEXANDRA ROSE |
1637 |
§103§112 |
Non-Final OA |
— |
Pending |
Aug 03, 2022 |
| 17879923 |
6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME |
Trevena, Inc. |
JAVANMARD, SAHAR |
1622 |
§102§103Other |
Final Rejection |
147d overdue |
Pending |
Aug 03, 2022 |
| 17815928 |
SAFE HARBOR LOCI |
Bit Bio Limited |
BRETZ, COREY LANE |
1600 |
§103 |
Final Rejection |
— |
Pending |
Jul 28, 2022 |
| 17759681 |
COMBINATIONS OF EGFR INHIBITORS AND ROR1 INHIBITORS FOR THE TREATMENT OF CANCER |
Ho'Ola Therapeutics Inc. |
CHASE, CAROL ANN |
1646 |
§103 |
Non-Final OA |
— |
Pending |
Jul 28, 2022 |
| 17812091 |
SECONDARY METHODS OF COMMUNICATING WITH A DRUG DELIVERY DEVICE |
Insulet Corporation |
PAZ ESTEVEZ, GUILLERMO G |
3783 |
§103 |
Non-Final OA |
— |
Pending |
Jul 12, 2022 |
| 17845275 |
USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA |
Deciphera Pharmaceuticals, LLC |
RODRIGUEZ, RAYNA B |
1628 |
§103§112 |
Final Rejection |
12d |
Pending |
Jun 21, 2022 |
| 17843167 |
METHODS, MEDIUMS, AND SYSTEMS FOR PREDICTING MOLECULE MODIFICATIONS |
Waters Technologies Ireland Limited |
REYES, REGINALD R |
3684 |
§101Other |
Final Rejection |
— |
Pending |
Jun 17, 2022 |
| 17839786 |
NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES |
Nucleus Medical GmbH |
LEE, SIN J |
1613 |
§103 |
Non-Final OA |
58d overdue |
Pending |
Jun 14, 2022 |
| 17785385 |
METHODS, KITS AND COMPOSITIONS FOR REDUCING CARDIOTOXICITY ASSOCIATED WITH CANCER THERAPIES |
Richard G. Pestell |
DENT, ALANA HARRIS |
1643 |
§102§103§112 |
Final Rejection |
53d overdue |
Pending |
Jun 14, 2022 |
| 17839647 |
METHOD FOR MODIFICATION OF MAXIMUM DELIVERY LIMITS IN AUTOMATIC DRUG DELIVERY SYSTEMS |
Insulet Corporation |
PRICE, NATHAN R |
3783 |
§101§102§112 |
Final Rejection |
— |
Pending |
Jun 14, 2022 |
| 17839645 |
HYBRID INJECTION-PUMP INSULIN DELIVERY |
Insulet Corporation |
PRICE, NATHAN R |
3783 |
§103§112 |
Final Rejection |
— |
Pending |
Jun 14, 2022 |
| 17838114 |
DURABLE VACCINATION |
Gritstone Bio, Inc. |
CHEN, STACY BROWN |
1672 |
§103§112DP |
Final Rejection |
— |
Pending |
Jun 10, 2022 |
| 17782239 |
Systems and Methods for Measuring Concentration of an Analyte |
Brolis Sensor Technology, Uab |
SMITH, EMILIE ALINE |
1686 |
§101§103 |
Non-Final OA |
— |
Pending |
Jun 03, 2022 |
| 17749449 |
METHODS, MEDIUMS, AND SYSTEMS FOR PROVIDING ASSISTED CALIBRATION FOR A MASS SPECTROMETRY APPARATUS |
Waters Technologies Ireland Limited |
OSENBAUGH-STEWART, ELIZA W |
2881 |
§103 |
Final Rejection |
34d |
Pending |
May 20, 2022 |
| 17744354 |
ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENS |
Gritstone Bio, Inc. |
LEE, YIE CHIA |
1642 |
§101§102§103§112 |
Non-Final OA |
— |
Pending |
May 13, 2022 |
| 17742998 |
METHODS AND DEVICES FOR DETERMINING FLUID DELIVERY PUMP INFORMATION |
Insulet Corporation |
SMALE, AVERY E |
3783 |
§103 |
Final Rejection |
— |
Pending |
May 12, 2022 |
| 17736738 |
SHARED NEOANTIGEN VACCINES |
Gritstone Bio, Inc. |
VIVLEMORE, TRACY ANN |
1638 |
§102Other |
Final Rejection |
141d overdue |
Pending |
May 04, 2022 |
| 17724876 |
GARMENT FOR TREATMENT OF INCONTINENCE |
Attn: Grace, Inc. |
HAN, SETH |
3781 |
§103 |
Non-Final OA |
4d overdue |
Pending |
Apr 20, 2022 |
| 17658817 |
SURGICAL FASTENERS, TOOLS, AND METHODS |
Arthrosurface, Inc. |
RAMANA, ANURADHA |
3775 |
§102§103Other |
Non-Final OA |
— |
Pending |
Apr 11, 2022 |
| 17768146 |
MODIFIED STEM CELLS AND METHODS OF USE THEREOF |
Arizona Board of Regents |
PENNINGTON, KATIE LEIGH |
1634 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Apr 11, 2022 |
| 17767687 |
Chimeric Cytokine Receptors |
UVIC INDUSTRY PARTNERSHIPS INC. |
GRABER, JAMES J |
1631 |
§103DP |
Final Rejection |
26d |
Pending |
Apr 08, 2022 |
| 17639401 |
METHODS OF TREATING EPILEPSY USING THE SAME |
Trevena, Inc. |
NESTOR, DONNA MICHELLE |
1627 |
§103Other |
Non-Final OA |
60d |
Pending |
Mar 01, 2022 |
| 17674093 |
DRIVE MECHANISMS FOR POSITIVE DISPLACEMENT PUMPS |
Insulet Corporation |
DESANTO, MATTHEW F |
3700 |
§102 |
Non-Final OA |
— |
Pending |
Feb 17, 2022 |
| 17635751 |
ORTHOPAEDIC DEVICE AND ENERGY STORAGE DEVICE |
Ottobock SE & Co. Kgaa |
DUDDEN, TERESA MARIE |
3774 |
§103§112 |
Final Rejection |
23d overdue |
Pending |
Feb 16, 2022 |
| 17669766 |
COMPOSITIONS AND METHODS OF THEIR USE |
Synedgen, Inc. |
BAKSHI, PANCHAM |
1623 |
§103DP |
Non-Final OA |
— |
Pending |
Feb 11, 2022 |
| 17665165 |
TECHNIQUES AND DEVICES FOR ADAPTATION OF MAXIMUM DRUG DELIVERY LIMITS |
Insulet Corporation |
DIOP, FATIMATA SAHRA |
3783 |
§103 |
Final Rejection |
— |
Pending |
Feb 04, 2022 |
| 17586238 |
ULINASTATIN POLYPEPTIDES FOR TREATING DISEASES |
Diamedica Usa Inc. |
HADDAD, MAHER M |
1641 |
DP |
Non-Final OA |
35d overdue |
Pending |
Jan 27, 2022 |
| 17581788 |
NEOANTIGEN IDENTIFICATION USING HOTSPOTS |
Gritstone Bio, Inc. |
WOITACH, JOSEPH T |
1687 |
§101§112Other |
Non-Final OA |
— |
Pending |
Jan 21, 2022 |
| 17580249 |
CONDUCTIVE ELEMENT IN ADHESIVE PATCH OF ON-BODY DRUG DELIVERY DEVICE FOR BODY CHANNEL COMMUNICATION |
Insulet Corporation |
GOLLAMUDI, NEERAJA |
3783 |
§103 |
Final Rejection |
— |
Pending |
Jan 20, 2022 |
| 17627477 |
PROCESS FOR SEPARATION AND QUANTITATION OF PROTEINS USING CAPILLARY ELECTROPHORESIS |
Kashiv Biosciences, LLC |
OSMAN, SOMMER YOUSEF |
1794 |
§103§112 |
Non-Final OA |
— |
Pending |
Jan 14, 2022 |
| 17574790 |
Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents |
VIRGINIA COMMONWEALTH UNIVERSITY |
SCHLIENTZ, LEAH H |
1618 |
§103 |
Non-Final OA |
12d |
Pending |
Jan 13, 2022 |
| 17624121 |
RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME |
Palleon Pharmaceuticals Inc. |
BORGEEST, CHRISTINA M |
1675 |
§102§112 |
Non-Final OA |
51d overdue |
Pending |
Dec 30, 2021 |
| 17624123 |
RECOMBINANT SIALIDASES AND METHODS OF USING THE SAME |
Palleon Pharmaceuticals Inc. |
WEHBE, ANNE MARIE SABRINA |
1634 |
§103§112 |
Final Rejection |
43d overdue |
Pending |
Dec 30, 2021 |
| 17559013 |
METHODS, MEDIUMS, AND SYSTEMS FOR STORING AND RETRIEVING CHROMATOGRAPHY DATA |
Waters Technologies Ireland Limited |
HYUN, PAUL SANG HWA |
1796 |
§112 |
Final Rejection |
5d |
Pending |
Dec 22, 2021 |
| 17554514 |
INTEGRATION OF A MEDICAMENT DELIVERY DEVICE WITH A SMARTWATCH AND A VEHICLE INFOTAINMENT SYSTEM |
Insulet Corporation |
PONTON, JAMES D |
3783 |
§103 |
Non-Final OA |
— |
Pending |
Dec 17, 2021 |
| 17620427 |
FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE |
BELITE BIO, LLC |
KUCHARCZK, JED A |
1623 |
§103 |
Final Rejection |
49d overdue |
Pending |
Dec 17, 2021 |
| 17552935 |
METHODS, MEDIUMS, AND SYSTEMS FOR BUILDING AND EXECUTING A CHROMATOGRAPHY WORKFLOW |
Waters Technologies Ireland Limited |
GAVIN, KRISTIN ELIZABETH |
3624 |
§101§112 |
Final Rejection |
99d overdue |
Pending |
Dec 16, 2021 |
| 17619036 |
COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES |
Dnalite Therapeutics, Inc. |
MITCHELL, EDWIN COLEMAN |
1619 |
§103§112 |
Final Rejection |
89d overdue |
Pending |
Dec 14, 2021 |
| 17616350 |
OLIGONUCLEOTIDES AND METHODS OF USE FOR TREATING NEUROLOGICAL DISEASES |
Quralis Corporation |
RAVINDRA, KRISHNA NUGGEHALLI |
1636 |
§103 |
Final Rejection |
— |
Pending |
Dec 03, 2021 |
| 17613927 |
RAPID AND DETERMINISTIC GENERATION OF MICROGLIA FROM HUMAN PLURIPOTENT STEM CELLS |
Westfälische Wilhelms-Universität Münster |
BATES, KEENAN ALEXANDER |
1631 |
§103 |
Final Rejection |
— |
Pending |
Nov 23, 2021 |
| 17532791 |
TRANSCRIPTIONAL RELAY SYSTEM |
Octant, Inc. |
STAVROU, CONSTANTINA E |
1632 |
§103 |
Final Rejection |
14d |
Pending |
Nov 22, 2021 |
| 17508556 |
METHODS AND ARRANGEMENTS TO MANAGE REQUIREMENTS AND CONTROLS, AND DATA AT THE INTERSECTION THEREOF |
State Street Corporation |
BADAWI, ANGIE M |
2179 |
§103 |
Non-Final OA |
7d |
Pending |
Oct 22, 2021 |
| 17505883 |
TECHNIQUES AND INSULIN PUMP FOR ENHANCED SITE HEALTH AND BLOOD GLUCOSE CONTROL FOR AID SYSTEMS |
Insulet Corporation |
GONG, KRIS HANYU |
3785 |
§103 |
Final Rejection |
— |
Pending |
Oct 20, 2021 |
| 17506145 |
BODY CONFORMING WEARABLE DEVICE FOR PROVIDING OUTPUT AND INPUT FOR A DRUG DELIVERY SYSTEM |
Insulet Corporation |
RODRIGUEZ, CRIS LOIREN |
3783 |
§102§103 |
Final Rejection |
7d |
Pending |
Oct 20, 2021 |
| 17440067 |
PEPTIDE-INDUCED NK CELL ACTIVATION |
UNIVERSITY OF SOUTHAMPTON |
DICKINSON, PAUL W |
1618 |
§103§112 |
Non-Final OA |
27d |
Pending |
Sep 16, 2021 |
| 17436367 |
IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL |
Gritstone Bio, Inc. |
NGUYEN, PETER |
1685 |
§101§103DP |
Final Rejection |
— |
Pending |
Sep 03, 2021 |
| 17446807 |
PRODRUG MODULATORS OF THE INTEGRATED STRESS PATHWAY |
AbbVie Inc. |
SHTERENGARTS, SAMANTHA L |
1623 |
§112 |
Non-Final OA |
— |
Pending |
Sep 02, 2021 |
| 17412684 |
SYSTEMS AND METHODS FOR ACTIVATING DRUG DELIVERY DEVICES |
Insulet Corporation |
VU, QUYNH-NHU HOANG |
3783 |
§103 |
Final Rejection |
29d |
Pending |
Aug 26, 2021 |
| 17446084 |
REMOTE MANAGEMENT OF A MEDICAMENT DELIVERY DEVICE USING DATA ANALYTICS |
Insulet Corporation |
VANDER WOUDE, KIMBERLY ELAINE |
3681 |
§101§103§112 |
Non-Final OA |
— |
Pending |
Aug 26, 2021 |
| 17412666 |
SIMPLIFIED WEARABLE DRUG DELIVERY DEVICE |
Insulet Corporation |
SMALE, AVERY E |
3783 |
§102§103§112 |
Non-Final OA |
— |
Pending |
Aug 26, 2021 |
| 17433817 |
SELECTION OF T CELL RECEPTORS |
Gritstone Bio, Inc. |
FAUST, AMBER KATHLEEN |
1643 |
§103 |
Final Rejection |
— |
Pending |
Aug 25, 2021 |
| 17426141 |
SURVIVAL-TARGETING CHIMERIC (SURTAC) MOLECULES |
Entact Bio Limited |
YAO, LEI |
1642 |
§112 |
Non-Final OA |
3d overdue |
Pending |
Jul 28, 2021 |
| 17420833 |
TREATMENT OF CANCER HAVING GNAQ OR GNA11 GENETIC MUTATIONS WITH PROTEIN KINASE C INHIBITORS |
Ideaya Biosciences, Inc. |
YOO, SUN JAE |
1621 |
— |
Non-Final OA |
— |
Pending |
Jul 06, 2021 |
| 17295782 |
COMPOSITIONS AND METHODS FOR INCREASING FETAL HEMOGLOBIN AND TREATING SICKLE CELL DISEASE |
Fulcrum Therapeutics, Inc. |
EBBINGHAUS, BRIANA NOEL |
1632 |
§112 |
Non-Final OA |
— |
Pending |
May 20, 2021 |
| 17291070 |
METHODS OF CELLULAR REPROGRAMMING |
BIOTISSUE HOLDINGS INC. |
BATES, KEENAN ALEXANDER |
1631 |
§103§112 |
Non-Final OA |
— |
Pending |
May 04, 2021 |
| 17271045 |
METHODS FOR REDUCING THE RISK OF DIABETES IN PATIENTS BEING TREATED FOR HIGH CHOLESTEROL-RELATED ILLNESSES |
Esperion Therapeutics, Inc. |
HUTTER, GILLIAN A |
1625 |
§102 |
Non-Final OA |
57d |
Pending |
Feb 24, 2021 |
| 17157043 |
Dynamically Changing Promotions Displayed on a Mobile Device and Measuring The Benefit Thereof |
UPSIDE SERVICES, INC. |
OSMAN BILAL AHMED, AFAF |
3622 |
§101§103 |
Final Rejection |
147d overdue |
Pending |
Jan 25, 2021 |
| 17150372 |
INTELLIGENT SITUATIONAL ALARMS AND NOTIFICATIONS FOR DIABETES MANAGEMENT DEVICES |
Insulet Corporation |
COBANOGLU, DILEK B |
3687 |
§101§102 |
Non-Final OA |
— |
Pending |
Jan 15, 2021 |
| 17058128 |
SHARED ANTIGENS |
Gritstone Oncology, Inc. |
MCLEOD, AFRICA MHAIRIE |
1600 |
§102§103DP |
Non-Final OA |
— |
Pending |
Nov 23, 2020 |
| 16952231 |
SYSTEMS AND METHODS FOR ANALYSIS OF ALTERNATIVE SPLICING |
Envisagenics, Inc. |
VASSELL, MEREDITH ABBOTT |
1687 |
§103§112 |
Final Rejection |
— |
Pending |
Nov 19, 2020 |
| 17096565 |
ADAPTIVE DURATION OF INSULIN ACTION FOR USE IN INSULIN ON BOARD CALCULATIONS |
Insulet Corporation |
JANG, CHRISTIAN Y |
3791 |
§112 |
Non-Final OA |
— |
Pending |
Nov 12, 2020 |
| 17054400 |
ARTIFICIAL FOOT |
Ottobock SE & Co. Kgaa |
SPENCER, MAXIMILIAN TOBIAS |
3774 |
§103 |
Non-Final OA |
— |
Pending |
Nov 10, 2020 |
| 17085344 |
SYSTEMS AND METHODS FOR DETERMINING PLACEMENT OF WEARABLE DRUG DELIVERY DEVICES |
Insulet Corporation |
TRINH, HONG-VAN N |
3783 |
§103 |
Non-Final OA |
— |
Pending |
Oct 30, 2020 |
| 17028595 |
INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) |
Avalyn Pharma Inc. |
HAGHIGHATIAN, MINA |
1616 |
§103§112 |
Final Rejection |
45d overdue |
Pending |
Sep 22, 2020 |
| 17008101 |
ADJUSTING SETTINGS TO DIFFERENT DEGREES OF AGGRESSIVENESS IN AN AUTOMATED INSULIN DELIVERY SYSTEM BASED ON QUALITY OF BLOOD GLUCOSE LEVEL CONTROL BY A USER |
Insulet Corporation |
KRETZER, KYLE W. |
3791 |
§103 |
Final Rejection |
12d |
Pending |
Aug 31, 2020 |
| 16975823 |
Neoantigen Identification with Pan-Allele Models |
Gritstone Bio,Inc. |
BAILEY, STEVEN WILLIAM |
1687 |
§101§103§112DP |
Final Rejection |
45d overdue |
Pending |
Aug 26, 2020 |
| 16995527 |
RATCHET DRIVE FOR ON BODY DELIVERY SYSTEM |
Insulet Corporation |
SWANSON, LEAH JENNINGS |
3783 |
§103§112 |
Final Rejection |
14d |
Pending |
Aug 17, 2020 |
| 16859544 |
FILLING ASSIST MECHANISMS AND KEYED INTERFACES FOR DRUG DELIVERY DEVICES |
Insulet Corporation |
SWANSON, LEAH JENNINGS |
3783 |
§102§103 |
Final Rejection |
3d overdue |
Pending |
Apr 27, 2020 |
Prosecution Insights